Category,FY,Funding IC,Project Number,Sub Project #,Project Title,PI Name,Org Name,State / Country,Amount
Prostate Cancer,2009,NCI,5R01CA068814-14,,Mechanisms of Metastasis in Experimental Prostate Cancer,"THOMPSON, TIMOTHY",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$296,750"
Prostate Cancer,2009,NCI,5K01CA114252-05,,ANDROGEN RECEPTOR SIGNALING IN SELENIUM CHEMOPREVENTION,"DONG, YAN",TULANE UNIVERSITY OF LOUISIANA,LA,"$153,662"
Prostate Cancer,2009,NCI,5R01CA122704-03,,Prostate Cancer Recovery Enhancement (PROCARE) for African American Men,"CAMPBELL, LISA",EAST CAROLINA UNIVERSITY,NC,"$387,697"
Prostate Cancer,2009,NCI,5R01CA116242-03,,Tea Polyphenols in Chemoprevention of Prostate Cancer,"HENNING, SUSANNE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$264,195"
Prostate Cancer,2009,NCI,5R01CA112310-05,,Role of Raf Kinase Inhibitory Protein in Prostate Cancer,"ROSNER, MARSHA",UNIVERSITY OF CHICAGO,IL,"$300,080"
Prostate Cancer,2009,NIDDK,5R37DK051193-14,,Role of U19/Eaf2 in androgen-dependent prostate homeostasis,"WANG, ZHOU",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$289,685"
Prostate Cancer,2009,NCI,5R01CA127300-02,,New Mice Models for Studies of Androgen Receptor in Prostate Cancer,"CHANG, CHAWNSHANG",UNIVERSITY OF ROCHESTER,NY,"$319,550"
Prostate Cancer,2009,NCI,5R01CA122247-02,,Targeting DHT Catabolism by AKR1Cs for Prostrate Cancer Prevention and Treatment.,"STOLZ, ANDREW",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$304,403"
Prostate Cancer,2009,NCI,5R01CA122246-02,,Pathogenetics of a Clinically-favorable Prostate Cancer Subtype,"POLLACK, JONATHAN",STANFORD UNIVERSITY,CA,"$206,190"
Prostate Cancer,2009,NCI,5R01CA105125-05,,Ceramide synthase as a therapy target in prostate cancer,"HAIMOVITZ-FRIEDMAN, ADRIANA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$319,439"
Prostate Cancer,2009,NCI,5R01CA119334-30,,Technetium and Rhenium in Nuclear Medicine,"JONES, ALUN",HARVARD UNIVERSITY (MEDICAL SCHOOL),MA,"$578,542"
Prostate Cancer,2009,NCI,5R21CA131774-02,,Small RNA targeted gene activation for the treatment of prostate cancer,"LI, LONG-CHENG",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$173,813"
Prostate Cancer,2009,NCI,5R01CA109147-04,,AR and RUNX2 target genes in prostate cancer,"COETZEE, GERHARD",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$252,841"
Prostate Cancer,2009,NCI,5R01CA114060-04,,SELECT Pre-Clinical Trial of Prostate Cancer,"AHMAD, NIHAL",UNIVERSITY OF WISCONSIN MADISON,WI,"$250,774"
Prostate Cancer,2009,NCI,5R01CA075284-10,,Improved Cryosurgical Destruction of Prostate Cancer,"BISCHOF, JOHN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$325,150"
Prostate Cancer,2009,NIGMS,5R01GM064559-08,,Heterocumulenes in Asymmetric Catalysis,"LECTKA, THOMAS",JOHNS HOPKINS UNIVERSITY,MD,"$260,996"
Prostate Cancer,2009,NCI,5R01CA069158-13,,TGFbeta IN THE BONE MICROENVIRONMENT: ROLE IN TUMOR METASTASIS,"GUISE, THERESA",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$276,088"
Prostate Cancer,2009,NCI,5R01CA111421-05,,Apoptosis by FADD in normal and cancerous cells,"THORBURN, ANDREW",UNIVERSITY OF COLORADO DENVER,CO,"$288,389"
Prostate Cancer,2009,NCI,5R01CA120451-03,,Pomegranate for Chemoprevention and Chemotherapy of Prostate Cancer,"MUKHTAR, HASAN",UNIVERSITY OF WISCONSIN MADISON,WI,"$279,300"
Prostate Cancer,2009,NCI,5R01CA102751-05,,MR Based Molecular Imaging of Prostate Cancer,"KURHANEWICZ, JOHN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$259,677"
Prostate Cancer,2009,NCI,5R01CA116673-03,,Clinical Trial of Selenium and Prostate Biomarkers,"MARSHALL, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$419,695"
Prostate Cancer,2009,NIEHS,5R01ES015584-02,,Epigenetic Basis for Prostate Carcinogenesis following Early Estrogenic Exposures,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$535,922"
Prostate Cancer,2009,NCI,5R01CA109460-04,,PI3K Pathway in Prostate Tumorigenesis and Angiogenesis,"JIANG, BING-HUA",WEST VIRGINIA UNIVERSITY,WV,"$227,246"
Prostate Cancer,2009,NCI,5R01CA111891-04,,delta-Catenin and Cell-Cell Adhesion in Prostate Cancer,"LU, QUN",EAST CAROLINA UNIVERSITY,NC,"$184,029"
Prostate Cancer,2009,NCI,5R01CA120921-02,,Regulation of androgen receptor by HER-2 and Ack1 tyrosine kinases,"WHANG, YOUNG",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$272,655"
Prostate Cancer,2009,NCI,5R21CA132033-02,,Targeted polymeric nanocarriers for combination therapy of metastatic prostate ca,"FORREST, MARCUS",UNIVERSITY OF KANSAS LAWRENCE,KS,"$208,389"
Prostate Cancer,2009,NCI,5R01CA097543-05,,Metabolism of Vitamin A in the Prostate,"GUDAS, LORRAINE",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$251,685"
Prostate Cancer,2009,NCI,5R01CA107039-05,,Rexinoid Synergy in Prostate Cancer Apoptosis,"DAWSON, MARCIA",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$529,569"
Prostate Cancer,2009,NCI,5R01CA112028-05,,Cell Cycle Variants and Metastatic Prostate Cancer Risk,"KIBEL, ADAM",WASHINGTON UNIVERSITY,MO,"$229,214"
Prostate Cancer,2009,NCI,5R21CA128352-02,,A phase II study of IPI-504 in metastatic hormone refractory prostate cancer,"OH, WILLIAM",DANA-FARBER CANCER INSTITUTE,MA,"$263,979"
Prostate Cancer,2009,NCI,5R01CA120386-03,,Role of Eaf family proteins in prostate carcinogenesis,"WANG, ZHOU",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$282,150"
Prostate Cancer,2009,NCI,5R21CA131754-02,,Decision Making in Patients with Advanced Prostate Cancer,"JONES, RANDY",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$182,443"
Prostate Cancer,2009,NCI,5R01CA119168-04,,Internet-Based Education for Prostate Cancer Screening,"TAYLOR, KATHRYN",GEORGETOWN UNIVERSITY,DC,"$381,219"
Prostate Cancer,2009,NCI,1R01CA136578-01,,Sex-Hormones and the TMPRSS2: ERG Fusion in Prostate Cancer Progression,"MUCCI, LORELEI",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$380,688"
Prostate Cancer,2009,NCI,1R01CA136953-01,,Prostate cancer chemoprevention by penta-galloyl-glucose,"LU, JUNXUAN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$316,438"
Prostate Cancer,2009,NCI,5R21CA129246-02,,Oncolytic activity of respiratory syncytial virus against prostate cancer,"BOSE, SANTANU",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$200,250"
Prostate Cancer,2009,NCI,5R01CA114379-03,,Prostate Cancer in a Black Population,"NEMESURE, BARBARA",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$803,013"
Prostate Cancer,2009,NCI,1U01CA136792-01,,A Genome-wide Association Study of Prostate Cancer in African Americans,"HENDERSON, BRIAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$3,454,975"
Prostate Cancer,2009,NCI,5R13CA121777-03,,Ephrins and Cancer,"DEBINSKI, WALDEMAR",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$9,000"
Prostate Cancer,2009,NCI,5R01CA118124-03,,Analysis of Homing Receptors in Prostate Cancer,"DIMITROFF, CHARLES",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$282,720"
Prostate Cancer,2009,NCI,5R01CA115717-03,,Modeling androgen-independent prostate cancer in mutant mice,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$305,900"
Prostate Cancer,2009,NCI,5R01CA127735-02,,A Role of Novel Serpin Maspinin Prostate Tumor/Bone Interaction,"SHENG, SHIJIE",WAYNE STATE UNIVERSITY,MI,"$312,288"
Prostate Cancer,2009,NCI,5R21CA133618-02,,Targeted Ceramic Nanovectors for Simultaneous Therapy and Imaging of Cancer,"DEY, SANDWIP",ARIZONA STATE UNIVERSITY-TEMPE CAMPUS,AZ,"$129,423"
Prostate Cancer,2009,NCI,5R21CA133456-02,,Chitosan-plasmid DNA nanoplexes and adenoviruses as prostate cancer vaccines,"SALEM, ALIASGER",UNIVERSITY OF IOWA,IA,"$168,750"
Prostate Cancer,2009,NCI,5R01CA113903-05,,Communication and Chemoprevention of Prostate Cancer,"MEHTA, PARMENDER",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$247,753"
Prostate Cancer,2009,NCI,1R01CA128932-01A2,,Bioflavonoid Effects on EGF Signaling and Cell Cycle Pathways in Prostate Cancer,"MARKAVERICH, BARRY",BAYLOR COLLEGE OF MEDICINE,TX,"$318,513"
Prostate Cancer,2009,NCI,5R01CA112663-10,,T-bet and Tumor Immunity,"GLIMCHER, LAURIE",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$297,398"
Prostate Cancer,2009,NCI,5R01CA123063-03,,Glycosaminoglycan-based inhibitors for treatment of prostate cancer,"LOKESHWAR, VINATA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$260,623"
Prostate Cancer,2009,NCI,1R21CA137490-01,,Mouse model of obesity and prostate cancer progression.,"HENRY, MICHAEL",UNIVERSITY OF IOWA,IA,"$163,835"
Prostate Cancer,2009,NCI,5R01CA059897-16,,METABOLIC IMAGING OF THE PROSTATE USING 3-D MRSI,"VIGNERON, DANIEL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$429,307"
Prostate Cancer,2009,NCI,5R01CA103934-04,,MR Diffusion Tensor Imaging of Prostate Cancer,"VIGNERON, DANIEL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$261,115"
Prostate Cancer,2009,NIDDK,5R01DK054257-11,,Molecular Complementation of Nuclear Receptors,"KOH, JOHN",UNIVERSITY OF DELAWARE,DE,"$265,106"
Prostate Cancer,2009,NCI,5R01CA131226-02,,Efficacy and Mechanism of Novel Androgen Receptor Inhibitors,"DIAMOND, MARC",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$320,588"
Prostate Cancer,2009,NCI,5R01CA095739-09,,Store-Operated Calcium Entry and Apoptosis,"MA, JIANJIE",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$245,631"
Prostate Cancer,2009,NCI,5R01CA104035-05,,A Novel Inhibitor of Stat3 for Prostate Cancer Therapy,"JING, NAIJIE",BAYLOR COLLEGE OF MEDICINE,TX,"$280,899"
Prostate Cancer,2009,NCI,1R15CA133623-01A1,,A microfluidic platform to study the effects of chemokine gradients on prostate c,"CHIAO, JUNG-CHIH",UNIVERSITY OF TEXAS ARLINGTON,TX,"$205,407"
Prostate Cancer,2009,NCI,5R01CA116636-04,,Prostate Cancer Chemoprevention by Inositol Hexaphosphate Efficacy and Mechanism,"AGARWAL, RAJESH",UNIVERSITY OF COLORADO DENVER,CO,"$261,235"
Prostate Cancer,2009,NIDDK,5K08DK081019-02,,Roles for Phospholipase A2 Signaling in Prostate Development,"SCHAEFFER, EDWARD",JOHNS HOPKINS UNIVERSITY,MD,"$157,248"
Prostate Cancer,2009,NCI,5R01CA109874-05,,Beta1 Integrins and IGF-I Receptor in Prostate Cancer,"LANGUINO, LUCIA",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$273,876"
Prostate Cancer,2009,NCI,5R21CA122570-02,,Profiling Urine Glycosylation of PSA and other Glyco-Biomarkers in Prostate Cance,"PANNELL, LEWIS",UNIVERSITY OF SOUTH ALABAMA,AL,"$198,450"
Prostate Cancer,2009,NCI,5R01CA127923-03,,IKK  and the control of prostate cancer metastasis,"KARIN, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$264,195"
Prostate Cancer,2009,NCI,2R01CA101753-06,,Anticarcinogenic Effect of ITCs Against Prostate Cancer,"SINGH, SHIVENDRA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$329,208"
Prostate Cancer,2009,NIDDK,5K24DK062895-07,,Osteoporosis in Older Men and Women,"GREENSPAN, SUSAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$179,857"
Prostate Cancer,2009,NIDDK,1R01DK079184-01A2,,"Sonic hedgehog, a regulator of CN injury induced apoptosis","PODLASEK, CAROL",NORTHWESTERN UNIVERSITY,IL,"$368,304"
Prostate Cancer,2009,NCI,5K07CA127214-02,,Genetic Susceptibility to Cancers of the Prostate and Urinary Bladder,"BEEBE-DIMMER, JENNIFER",WAYNE STATE UNIVERSITY,MI,"$132,816"
Prostate Cancer,2009,NCI,5R01CA115527-03,,Targeting Nanoparticle DNA Delivery to Prostate Tumors,"SAWICKI, JANET",LANKENAU INSTITUTE FOR MEDICAL RESEARCH,PA,"$334,661"
Prostate Cancer,2009,NCI,5R01CA112303-05,,Membrane Microdomains in Prostate Cancer,"FREEMAN, MICHAEL",CHILDREN'S HOSPITAL BOSTON,MA,"$284,832"
Prostate Cancer,2009,NCI,5R01CA111846-04,,Prx1 in malignant progression of prostate cancer,"JOHNSON, CANDICE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$311,125"
Prostate Cancer,2009,NCI,1R01CA131255-01A1,,In vivo effects of sulforaphane supplementation on normal human prostate,"LIN, DANIEL",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$454,948"
Prostate Cancer,2009,NCI,1R01CA127727-01A2,,Alternative splicing and epithelial-mesenchymal plasticity in prostate tumors,"GARCIA-BLANCO, MARIANO",DUKE UNIVERSITY,NC,"$323,700"
Prostate Cancer,2009,NCI,5R01CA108675-06,,AR intracellular trafficking in prostate cancer,"WANG, ZHOU",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$247,682"
Prostate Cancer,2009,NCI,5R01CA118947-04,,Chemopreventive Signaling Mechanisms in Prostate Cancer,"KONG, AH-NG",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$260,445"
Prostate Cancer,2009,NCI,5R01CA113363-05,,Prostate Cancer Prevention by Diallyl Trisulfide,"SINGH, SHIVENDRA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$276,692"
Prostate Cancer,2009,NCI,9R01CA139818-05A2,,Molecular Determinants of Androgen Receptor Pharmacology,"MCDONNELL, DONALD",DUKE UNIVERSITY,NC,"$353,034"
Prostate Cancer,2009,NCI,1R01CA132874-01A1,,Molecuar Sub-typing of Prostate Cancer Based on Recurrent Gene Fusions,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$256,470"
Prostate Cancer,2009,NCI,5R01CA122906-03,,Dietary histone deactylase inhibitors in prostate cancer prevention,"HO, EMILY",OREGON STATE UNIVERSITY,OR,"$278,659"
Prostate Cancer,2009,NCI,1R01CA129140-01A2,,Adiposity and Outcomes of Clinically Localized Prostate Cancer,"FREEMAN, VINCENT",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$660,462"
Prostate Cancer,2009,NCI,1R01CA127493-01A2,,Improving Urinary Continence and Quality of Life in Prostate Cancer Patients,"ZHANG, AMY",CASE WESTERN RESERVE UNIVERSITY,OH,"$785,297"
Prostate Cancer,2009,NCI,5R01CA114347-05,,NMR detection of tumor differentiation,"DELIKATNY, EDWARD",UNIVERSITY OF PENNSYLVANIA,PA,"$237,454"
Prostate Cancer,2009,NCI,5R01CA094858-07,,Modeling Prostate Tumorigenesis,"ABDULKADIR, SARKI",VANDERBILT UNIVERSITY,TN,"$230,554"
Prostate Cancer,2009,NCI,5R01CA132831-02,,DOUBLE-TARGETED MACROMOLECULAR THERAPEUTICS FOR THE TREATMENT OF PROSTATE CANCER,"KOPECEK, JINDRICH",UNIVERSITY OF UTAH,UT,"$312,288"
Prostate Cancer,2009,NCI,1R01CA134493-01A1,,A Platform for Cancer Biomarker Validation: Image Fusion Using NIR Fluorescence,"FRANGIONI, JOHN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$745,852"
Prostate Cancer,2009,NCI,2R01CA089569-06A2,,Prostate Cancer Metastatic Colonization: Role of MKK4,"RINKER-SCHAEFFER, CARRIE",UNIVERSITY OF CHICAGO,IL,"$328,815"
Prostate Cancer,2009,NCI,1R01CA131338-01A2,,The role of germline and somatic DNA changes at 8q24 in PCa risk,"ZHENG, SIQUN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$597,169"
Prostate Cancer,2009,NCI,5R01CA102102-05,,BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGS,"ROHR, JURGEN",UNIVERSITY OF KENTUCKY,KY,"$246,853"
Prostate Cancer,2009,NCI,5R01CA109441-05,,IL-4 and androgen receptor signaling in prostate cancer,"GAO, ALLEN",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$213,141"
Prostate Cancer,2009,NCI,5R01CA118887-04,,Selenium regulates androgen receptor signaling in prostate cancer,"GAO, ALLEN",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$235,778"
Prostate Cancer,2009,NCI,1R01CA127901-01A2,,Skp2 in androgen-dependent proliferation of prostate cancer cells,"ZHU, LIANG",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$310,005"
Prostate Cancer,2009,NCI,5R01CA122332-03,,Role of the tumor suppressor KLF6 in prostate cancer,"MARTIGNETTI, JOHN",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$315,400"
Prostate Cancer,2009,NCI,5R01CA111618-05,,Protocadherin-PC and Prostate Cancer,"BUTTYAN, RALPH","ORDWAY RESEARCH INSTITUTE, INC.",NY,"$275,333"
Prostate Cancer,2009,NIDDK,5R01DK052659-10,,Tyrosine Kinases and Prostate Cancer,"KUNG, HSING-JIEN",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$314,832"
Prostate Cancer,2009,NCI,1R21CA137708-01,,Array-Assisted Insertional Mutagenesis for Molecular Analysis of Cancer,"KANDEL, EUGENE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$271,670"
Prostate Cancer,2009,NCI,1R21CA137704-01,,Proximal Prostate Fluids for Protein and miRNA Biomarkers,"DRAKE, RICHARD",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$189,420"
Prostate Cancer,2009,NCI,5R21CA133634-02,,Prostate Fusion Gene Variants as a Cancer Biomarker,"LIU, YU-TSUENG",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$208,575"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5083,5-Alpha-Reductase Inhibition in Intermittent Androgen Ablation Therapy in Prostat,"WANG, ZHOU",UNIVERSITY OF PITTSBURGH,PA,"$320,176"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5084,PEDF Regulation of Adipogenesis and Leptin in Prostate Cancer,"CRAWFORD, SUSAN",NORTHWESTERN UNIVERSITY,IL,"$213,679"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5085,Radiation Inducible TNF-a Therapy for Prostate Cancer,"WEICHSELBAUM, RALPH",UNIVERSITY OF CHICAGO,IL,"$325,545"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5086,Modulation of Prostate Cancer Cell Motility by Chemopreventive Agent Genistein,"BERGAN, RAYMOND",NORTHWESTERN UNIVERSITY,IL,"$215,043"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5087,Administrative Core,"LEE, CHUNG",NORTHWESTERN UNIVERSITY,IL,"$249,698"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5088,Biostatistics/Bioinformatics Core,"JOVANOVIC, BORKO",NORTHWESTERN UNIVERSITY,IL,"$208,192"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5089,Clinical Trials and Advocacy Core,"KUZEL, TIMOTHY",NORTHWESTERN UNIVERSITY,IL,"$282,908"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5090,Specimen Procurement Core,"KAUL, KAREN",NORTHSHORE UNIV HEALTHSYSTEM RES INST,IL,"$302,299"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5091,Developmental Research Program,"LEE, CHUNG",NORTHWESTERN UNIVERSITY,IL,"$184,132"
Prostate Cancer,2009,NCI,2P50CA090386-06A2,5092,Career Development Program,"LEE, CHUNG",NORTHWESTERN UNIVERSITY,IL,"$61,375"
Prostate Cancer,2009,NCCAM,5R01AT002890-03,,Novel Herbal Medicine for the Treatment of Prostate Cancer,"CHENDIL, DAMODARAN",UNIVERSITY OF KENTUCKY,KY,"$354,641"
Prostate Cancer,2009,NCI,1R21CA131646-01A2,,"Dietary Folate: Impact on Prostate Tumor Biology, Genetics and Epigenetics","SMIRAGLIA, DOMINIC",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$229,580"
Prostate Cancer,2009,NCI,1R43CA137737-01,,Primary Xenografts of Human Tissue as Surrogates of Cancer In Situ,"ZWICK, MICHAEL","ANDROBIOSYS, INC.",NY,"$139,945"
Prostate Cancer,2009,NCI,5R21CA127784-02,,"""Strength training, Self-efficacy, and Function in Blacks with Prostate Cancer.""","HURLEY, BERNARD",UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS,MD,"$199,964"
Prostate Cancer,2009,NCI,5R03CA133941-02,,Tocopherylquinone as a novel chemopreventive agent for prostate cancer,"THOMPSON, TODD",UNIVERSITY OF NEW MEXICO,NM,"$75,000"
Prostate Cancer,2009,NCI,1R21CA133895-01A1,,"Exercise Training, Erectile Dysfunction, and Prostate Cancer","JONES, LEE",DUKE UNIVERSITY,NC,"$156,715"
Prostate Cancer,2009,NCI,1R21CA135586-01A1,,Internalizing antibody-targeted nanosized siRNA therapeutics,"LIU, BIN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$169,950"
Prostate Cancer,2009,NIDDK,5R01DK079962-02,,SOX9 in prostate cancer development and progression,"YUAN, XIN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$361,250"
Prostate Cancer,2009,NCI,5R01CA116337-04,,"""Molecular Signatures of Lethal and Indolent Prostate Cancer""","RUBIN, MARK",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$514,171"
Prostate Cancer,2009,NCI,1R21CA135560-01A1,,Indole-3-carbinol derivatives with enhanced chemopreventive activities,"CHEN, CHING-SHIH",OHIO STATE UNIVERSITY,OH,"$165,000"
Prostate Cancer,2009,NCI,5R01CA097134-07,,Repressors in Prostate Cancer,"ROSENFELD, MICHAEL",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$311,178"
Prostate Cancer,2009,NCI,5R21CA129265-02,,Role of NCoR in Antiandrogen Resistance in Prostate Cancer,"AGOULNIK, IRINA",BAYLOR COLLEGE OF MEDICINE,TX,"$172,688"
Prostate Cancer,2009,NCI,5R01CA121110-02,,Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma,"WU, HONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$315,680"
Prostate Cancer,2009,NCRR,1S10RR025631-01,,Time-of-Flight Mass Spectrometer for Synthesis Supporting Biomedical Research,"HOUK, KENDALL",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$328,092"
Prostate Cancer,2009,NCI,5R01CA076581-10,,Enhancing Suicide Gene Therapy Through Mechanism-Based Approaches,"SHEWACH, DONNA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$270,180"
Prostate Cancer,2009,NIEHS,5R01ES011126-08,,A Nested Case-Control Study of Prostate Carcinogenesis,"RYBICKI, BENJAMIN",HENRY FORD HEALTH SYSTEM,MI,"$592,441"
Prostate Cancer,2009,NIA,5R01AG019241-07,,Prevention of Alzheimer's Diseae by Vitamin E and Selenium,"MARKESBERY, WILLIAM",UNIVERSITY OF KENTUCKY,KY,"$1,295,383"
Prostate Cancer,2009,NCI,5R01CA121459-04,,Role of ATBF1 inactivation in the development and progression of prostate cancer,"DONG, JIN-TANG",EMORY UNIVERSITY,GA,"$263,700"
Prostate Cancer,2009,NICHD,5R01HD048843-04,,Studies on the Eppin family of proteins on chromosome 20,"O'RAND, MICHAEL",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$288,281"
Prostate Cancer,2009,NCI,5R01CA119125-04,,Resistance and Response Mechanisms to Prostate Cancer Therapy,"BEER, TOMASZ",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$337,853"
Prostate Cancer,2009,NCI,5R01CA087869-09,,"Epigenetics, Stem Cells, and Cancer","JAENISCH, RUDOLF",WHITEHEAD INSTITUTE FOR BIOMEDICAL RES,MA,"$886,353"
Prostate Cancer,2009,NCI,5R01CA109246-05,,MR Guided Focused Ultrasound Surgery for Prostate Cancer,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$436,323"
Prostate Cancer,2009,NCI,5U01CA086402-10,,San Antonio Center - Biomarkers for Prostate Cancer,"THOMPSON, IAN",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$930,596"
Prostate Cancer,2009,NIDDK,5R01DK058859-09,,Natural History of Prostatism: The Olmsted County Study,"ST SAUVER, JENNIFER","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$551,055"
Prostate Cancer,2009,NCI,5R01CA113996-04,,Integrin alpha6beta4 Signaling in Prostate Carcinoma Growth and Invasion,"GIANCOTTI, FILIPPO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$392,977"
Prostate Cancer,2009,NCI,5R01CA129684-02,,Confirmation of SNPs Associated with Aggressive PCa in a GWA Study,"XU, JIANFENG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$603,750"
Prostate Cancer,2009,NCI,7R01CA133458-02,,Integrative Metabolomics of Prostate Cancer Progression,"SREEKUMAR, ARUN",MEDICAL COLLEGE OF GEORGIA (MCG),GA,"$320,525"
Prostate Cancer,2009,NCI,5R01CA085567-07,,The Role of CDK5 in Metastasis,"NELKIN, BARRY",JOHNS HOPKINS UNIVERSITY,MD,"$350,509"
Prostate Cancer,2009,NCI,5R21CA133338-02,,Imaging Prostate Cancer with SQUID-Detected Microtesla MRI,"CLARKE, JOHN",UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB,CA,"$184,448"
Prostate Cancer,2009,NCI,1R41CA137881-01,,Development of an anti-PSA IgE to treat prostate cancer,"SCHULTES, BIRGIT","ADVANCED IMMUNE THERAPEUTICS, INC.",MA,"$158,851"
Prostate Cancer,2009,NCI,1R43CA137877-01,,Improving the Distribution of Geranylgeranyl Diphosphate synthase inhibitors.,"NEIGHBORS, JEFFREY","TERPENOID THERAPEUTICS, INC.",IA,"$114,959"
Prostate Cancer,2009,NCI,5R01CA113392-05,,Bone matrix proteins in prostate cancer progression,"ROY-BURMAN, PRADIP",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$305,244"
Prostate Cancer,2009,NIGMS,1R42GM086925-01,,Aptamer-based Glycomics Tools,"WANG, BINGHE","ECHELON BIOSCIENCES, INC.",UT,"$277,549"
Prostate Cancer,2009,NCI,5R01CA111803-03,,Targeting AR-NCoR Interaction in Prostate Cancer,"BALK, STEVEN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$323,000"
Prostate Cancer,2009,NCI,5R01CA106584-05,,Role of hyaluronan matrix in prostate cancer progression,"SIMPSON, MELANIE",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$205,583"
Prostate Cancer,2009,NCI,5R01CA129105-02,,Cell Growth Signaling in Cancer Development,"SABATINI, DAVID",WHITEHEAD INSTITUTE FOR BIOMEDICAL RES,MA,"$406,715"
Prostate Cancer,2009,NCI,5R21CA125428-02,,Decision Making in Unaffected First-Degree Relatives of Prostate Cancer Patients,"GWEDE, CLEMENT",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$225,113"
Prostate Cancer,2009,NIDDK,5R01DK065837-05,,PROSTATE CANCER BONE METASTASES: ROLE OF ADRENOMEDULLIN,"GUISE, THERESA",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$333,010"
Prostate Cancer,2009,NIBIB,2R44EB007857-02,,Ultrasound Contrast Agents for Inflammation and Angiogenesis,"RYCHAK, JOSHUA","TARGESON, LLC",VA,"$518,275"
Prostate Cancer,2009,NCI,5R01CA111479-05,,Bone Metastasis Factor-1 in Prostate Cancer/Bone Interaction,"LIN, SUE-HWA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$254,494"
Prostate Cancer,2009,NCI,5R01CA115985-05,,Molecular analysis of metastatic prostate cancer in mice,"SHEN, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$301,498"
Prostate Cancer,2009,NCI,5R01CA058073-16,,Molecular Mechanisms of Growth Control in Prostate Cancer,"LIAO, SHUTSUNG",UNIVERSITY OF CHICAGO,IL,"$315,168"
Prostate Cancer,2009,NIDCR,5R01DE013158-09,,UDP-GLUCURONOSYLTRANSFERASE GENOTYPE AND CANCER RISK,"LAZARUS, PHILIP",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$497,789"
Prostate Cancer,2009,NCI,5R01CA065435-11,,QUALITY RESEARCH IN RADIATION ONCOLOGY: ACR PCS,"WILSON, JESSE",AMERICAN COLLEGE OF RADIOLOGY,VA,"$564,543"
Prostate Cancer,2009,NIBIB,5R01EB007588-03,,TECHNIQUE DEVELOPMENT FOR HYPERPOLARIZED C-13 MR STUDIES,"VIGNERON, DANIEL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$518,373"
Prostate Cancer,2009,NCI,5R01CA120413-02,,Mechanisms of radiosensitization by 2-methoxyestradiol in prostate cancer models,"LARNER, JAMES",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$314,363"
Prostate Cancer,2009,NCI,5R37CA037393-28,,Modulators of Prostate Cancer Metastasis,"ZETTER, BRUCE",CHILDREN'S HOSPITAL BOSTON,MA,"$434,254"
Prostate Cancer,2009,NIA,5R01AG024278-04,,Genetic Analysis of a Prostate Tumor Suppressor Region,"MARKER, PAUL",UNIVERSITY OF WISCONSIN MADISON,WI,"$289,683"
Prostate Cancer,2009,NIDDK,5R01DK076763-03,,Prolactin receptor signaling of prolactin metabolic effects in the prostate,"FRANKLIN, RENTY",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$298,337"
Prostate Cancer,2009,NIA,5R01AG029804-03,,"3D Prostate Cancer Imaging Based on ""Crawling Wave"" Excitation","RUBENS, DEBORAH",UNIVERSITY OF ROCHESTER,NY,"$692,353"
Prostate Cancer,2009,NCI,5R01CA085912-10,,Functional Analysis of the PTEN Tumor Suppressor Protein,"GARRAWAY, LEVI",DANA-FARBER CANCER INSTITUTE,MA,"$265,975"
Prostate Cancer,2009,NIDDK,5U01DK063883-07,,Alternate Therapies for Benign Prostate Symptoms,"MCCULLOUGH, ANDREW",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$198,610"
Prostate Cancer,2009,NCI,5R01CA119935-03,,Vav3 Oncogene in Prostate Cancer,"LU, SHAN",UNIVERSITY OF CINCINNATI,OH,"$266,760"
Prostate Cancer,2009,NCI,5R01CA077789-11,,Phase III Trial of Selenium for Prostate Cancer Prevention,"AHMANN, FREDERICK",UNIVERSITY OF ARIZONA,AZ,"$607,234"
Prostate Cancer,2009,NCI,5R01CA115498-05,,Prevention of Prostate Cancer by Sulforaphane,"SINGH, SHIVENDRA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$276,934"
Prostate Cancer,2009,NCI,5R03CA133901-02,,Characterizing Potential Redox Mechanisms of Prostate Cancer Chemoprevention by E,"HAIL, NUMSEN",UNIVERSITY OF COLORADO DENVER,CO,"$76,813"
Prostate Cancer,2009,NIDDK,5R01DK056238-08,,The Shh-Gli Pathway Regulates Prostate Growth,"BUSHMAN, WADE",UNIVERSITY OF WISCONSIN MADISON,WI,"$286,759"
Prostate Cancer,2009,NCI,5U01CA086323-10,,Development/Clinical Validation Markers for Prostate Ca,"PARTIN, ALAN",JOHNS HOPKINS UNIVERSITY,MD,"$718,527"
Prostate Cancer,2009,NCI,2P01CA098912-06,8182,Biology of Tumor-Stroma Interaction,"CHUNG, LELAND",EMORY UNIVERSITY,GA,"$303,635"
Prostate Cancer,2009,NCI,2P01CA098912-06,8184,Heparan Sulfate Proteoglycans in Bone Stromal Metastasis,"FARACH-CARSON, MARY",UNIVERSITY OF DELAWARE,DE,"$404,376"
Prostate Cancer,2009,NCI,2P01CA098912-06,8185,Mitochondrial DNA Mutations in Prostate Tumorigenesis and Stromal-Epithelial Inte,"PETROS, JOHN",EMORY UNIVERSITY,GA,"$402,780"
Prostate Cancer,2009,NCI,2P01CA098912-06,8186,Administrative and Service Core,"CHUNG, LELAND",EMORY UNIVERSITY,GA,"$152,469"
Prostate Cancer,2009,NCI,2P01CA098912-06,8187,Bioinformatics. Biostatistics. and Translational (BBT) Core,"ROGATKO, ANDRE",EMORY UNIVERSITY,GA,"$101,689"
Prostate Cancer,2009,NCI,2P01CA098912-06,8188,Pathology and Laboratory Support Core,"ZAYZAFOON, MAJD",UNIVERSITY OF ALABAMA BIRMINGHAM,AL,"$286,410"
Prostate Cancer,2009,NCI,5R01CA112250-05,,Targeting Akt and Bcl-2 in Prostate Cancer Prevention,"CHEN, CHING-SHIH",OHIO STATE UNIVERSITY,OH,"$279,963"
Prostate Cancer,2009,NCI,5R01CA106504-05,,Molecular Mechanisms of Hormone-independence of Prostate Cancer,"QIU, YUN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$250,280"
Prostate Cancer,2009,NCI,5R21CA124786-02,,Trajectories of QOL in Prostate Cancer Survivors using Growth Curve Modeling,"DIEFENBACH, MICHAEL",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$198,210"
Prostate Cancer,2009,NCI,5R01CA116658-05,,Regulation of Cell Survival and Tumor Progression by Akt,"RANGNEKAR, VIVEK",UNIVERSITY OF KENTUCKY,KY,"$246,909"
Prostate Cancer,2009,NCI,5R01CA126847-07,,Role of Integrins and bone matrix in prostate cancer,"BYZOVA, TATIANA",CLEVELAND CLINIC LERNER COL/MED-CWRU,OH,"$281,757"
Prostate Cancer,2009,NCI,5R01CA076423-10,,Imaging in Risk Assessment of Prostate Cancer Patients,"HRICAK, HEDVIG",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$272,693"
Prostate Cancer,2009,NCI,5R01CA101904-07,,Gene-Based Imaging and Therapy to Target Metastatic Prostate Cancer,"WU, LILY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$287,595"
Prostate Cancer,2009,NCI,5R01CA116777-04,,Role of BAF57 in AR control and prostate cancer growth,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$266,285"
Prostate Cancer,2009,NCI,5R01CA112532-04,,Hormone-induced inflammation and prostate cancer,"HO, SHUK-MEI",UNIVERSITY OF CINCINNATI,OH,"$264,562"
Prostate Cancer,2009,NIEHS,5R01ES013557-04,,BIOSENSOR ARRAYS BASED ON SINGLE WALL CARBON NANOTUBES,"RUSLING, JAMES",UNIVERSITY OF CONNECTICUT STORRS,CT,"$393,044"
Prostate Cancer,2009,NCI,5R01CA114575-05,,Androgen signaling and kinase regulation in PCA,"KUNG, HSING-JIEN",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$224,441"
Prostate Cancer,2009,NCI,5R01CA095589-06,,"Dietary Patterns, Diet Quality + Cancer Risk","HU, FRANK",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$328,698"
Prostate Cancer,2009,NCI,5R01CA111966-05,,Loss of Nkx3.1-an Initiating Event in Prostate Cancer,"MILBRANDT, JEFFREY",WASHINGTON UNIVERSITY,MO,"$284,645"
Prostate Cancer,2009,NCI,5R01CA087921-09,,Overexpression of ubiquitin E3 ligase WWP1 as an oncogenic factor in the prostate,"DONG, JIN-TANG",EMORY UNIVERSITY,GA,"$240,227"
Prostate Cancer,2009,NCI,5R01CA111981-05,,Precise MRI-Directed Sonic Ablation of Prostate Cancer,"SOMMER, FRANK",STANFORD UNIVERSITY,CA,"$539,287"
Prostate Cancer,2009,NCI,5R01CA050588-21,,Mechanisms of Progression in Oncogene-Incuded Prostate Cancer,"THOMPSON, TIMOTHY",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$325,941"
Prostate Cancer,2009,NIDDK,5U01DK063825-07,,Clinical Evaluation & Treatment Center for Benign Prostatic Hyperplasia,"ANDRIOLE, GERALD",WASHINGTON UNIVERSITY,MO,"$149,602"
Prostate Cancer,2009,NCI,5R01CA121153-03,,"Development of Highly Targeted, Imageable Adenoviral Vectors for Prostate Cancer","RODRIGUEZ, RONALD",JOHNS HOPKINS UNIVERSITY,MD,"$311,600"
Prostate Cancer,2009,NCI,1R21CA131395-01A2,,Ultrasound guided site-specific gene delivery in prostate cancer,"CLAUDIO, PIER PAOLO",MARSHALL UNIVERSITY,WV,"$184,800"
Prostate Cancer,2009,NCI,5R01CA123484-03,,Role of Oncogenic Kinase Pim-1 in Prostate Cancer,"ABDULKADIR, SARKI",VANDERBILT UNIVERSITY,TN,"$291,406"
Prostate Cancer,2009,NCI,5K08CA122833-03,,High-resolution genome-wide mapping of structural mutations in prostate cancer,"BEROUKHIM, RAMEEN",DANA-FARBER CANCER INSTITUTE,MA,"$139,320"
Prostate Cancer,2009,NCI,5R01CA084202-09,,Role of CEACAM1 in Epithelial Cell Polarization,"SHIVELY, JOHN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$416,403"
Prostate Cancer,2009,NCI,5R01CA090744-08,,Human aldo-keto reductases and nuclear receptor action,"PENNING, TREVOR",UNIVERSITY OF PENNSYLVANIA,PA,"$254,602"
Prostate Cancer,2009,NIDDK,5U01DK063835-07,,Alternate Therapies for Benign Prostate Symptoms,"ROEHRBORN, CLAUS",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$198,925"
Prostate Cancer,2009,NCI,5R01CA121211-03,,Dietary Chemopreventive Components/Oncogene Interaction and Cancer,"ZHANG, RUIWEN",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$275,500"
Prostate Cancer,2009,NCI,5R01CA125747-07,,Androgenic Inactivation of FOXO1 in Prostate Cancer,"TINDALL, DONALD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$263,376"
Prostate Cancer,2009,NCI,5R01CA083695-07,,Molecular Mechanism of Genistein (Isoflavone) in Prostate Cancer,"SARKAR, FAZLUL",WAYNE STATE UNIVERSITY,MI,"$268,293"
Prostate Cancer,2009,NCI,5K24CA121990-03,,Midcareer Investigator Award,"SMITH, MATTHEW",MASSACHUSETTS GENERAL HOSPITAL,MA,"$193,249"
Prostate Cancer,2009,NCI,5K25CA114254-04,,Prostate Cancer Management with Multimodality Imaging,"SEO, YOUNGHO",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$137,476"
Prostate Cancer,2009,NCI,5R01CA116815-05,,Apoptotic effect of zinc in targeting prostate cancer,"FENG, PEI",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$247,193"
Prostate Cancer,2009,NCI,5R01CA120469-04,,Biochemical markers of bone turnover in metastatic prostate cancer,"LARA, PRIMO",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$274,669"
Prostate Cancer,2009,NCI,5R03CA136030-02,,Targeting Egr-1 with Curcumin Analogs for Prostate Cancer Prevention,"BISOFFI, MARCO",UNIVERSITY OF NEW MEXICO,NM,"$75,000"
Prostate Cancer,2009,NCI,5R01CA113580-04,,Stat5 in Progression of Prostate Cancer,"NEVALAINEN, MARJA",THOMAS JEFFERSON UNIVERSITY,PA,"$267,147"
Prostate Cancer,2009,NCI,5R01CA125661-03,,Regulator of G-protein Signaling (RGS) Proteins in Prostate Cancer,"TU, YAPING",CREIGHTON UNIVERSITY,NE,"$245,761"
Prostate Cancer,2009,NCI,5R01CA079683-10,,TGF beta Receptor and Tumor Progression,"SUN, LUZHE",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$160,226"
Prostate Cancer,2009,NCI,5R01CA115491-03,,Molecular Mechanisms of GSTP1 Reactivation by Green Tea Polyphenols,"GUPTA, SANJAY",CASE WESTERN RESERVE UNIVERSITY,OH,"$264,195"
Prostate Cancer,2009,NCI,5R01CA083940-09,,PTH-related peptide and vit D in prostate cancer growth,"FALZON, MIRIAM",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$225,501"
Prostate Cancer,2009,NIGMS,1SC3GM087201-01,,Novel nanotechnology approach to target prostate cancer,"KAZANSKY, ALEXANDER",UNIV/TEXAS BROWNSVILLE & SOUTHMOST COLL,TX,"$93,953"
Prostate Cancer,2009,NCI,5R01CA132803-02,,LHRH Agonist Therapy and Cognitive Functioning in Men with Prostate Cancer,"JACOBSEN, PAUL",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$404,858"
Prostate Cancer,2009,NIDDK,5K23DK071262-05,,Prostate Cancer Detection by Molecular Urinalysis,"PAVLOVICH, CHRISTIAN",JOHNS HOPKINS UNIVERSITY,MD,"$134,730"
Prostate Cancer,2009,NCI,5R01CA122060-03,,Phase II Clinical Trial of Polyphenon E in Prostate Cancer,"KUMAR, NAGI",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$707,275"
Prostate Cancer,2009,NCI,5R01CA118218-03,,Replicative Adenovirus and Anti-angiogenic Therapy,"KAO, CHINGHAI",INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS,IN,"$287,850"
Prostate Cancer,2009,NCI,5R01CA114539-04,,Human and Computer Mentors for Prostate Cancer Patients,"HAWKINS, ROBERT",UNIVERSITY OF WISCONSIN MADISON,WI,"$305,672"
Prostate Cancer,2009,NCI,5R01CA124925-03,,Prostate Cancer Screening With Electrical Impedance Measurements,"HARTOV, ALEXANDER",DARTMOUTH COLLEGE,NH,"$217,769"
Prostate Cancer,2009,NCI,5R01CA123194-03,,Agents for Specific NMR and SQUID Imaging of Prostate Cancer,"SILLERUD, LAUREL",UNIVERSITY OF NEW MEXICO,NM,"$454,956"
Prostate Cancer,2009,NCI,5R01CA120933-03,,Assessment of Cognitive & Mood Effects from ADT in Men with Prostate Cancer,"CHERRIER, MONIQUE",UNIVERSITY OF WASHINGTON,WA,"$218,116"
Prostate Cancer,2009,NCI,5K07CA109511-05,,Systematic Approaches to Supportive Care in Prostate CA,"FROMME, ERIK",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$137,620"
Prostate Cancer,2009,NCI,5R01CA111288-04,,Enabling Technologies for MRI-Guided Prostate Interventions,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$750,573"
Prostate Cancer,2009,NCI,5U01CA114583-05,,CNP for Older Underserved African American Adults,"ALBRECHT, TERRANCE",WAYNE STATE UNIVERSITY,MI,"$184,349"
Prostate Cancer,2009,NCI,5U01CA113913-05,,Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr,"SANDA, MARTIN",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$843,497"
Prostate Cancer,2009,NIDDK,5R01DK068503-05,,BRK/Sik Tyrosine Kinase Signaling in the Prostate,"TYNER, ANGELA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$263,020"
Prostate Cancer,2009,NCI,1R01CA129127-01A2,,The role of PKD3 in prostate carcinogenesis,"WANG, QIMING",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$314,363"
Prostate Cancer,2009,NCI,5R01CA135451-02,,TARGETING FLIP FOR PROSTATE CANCER PREVENTION,"KUMAR, ADDANKI",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$307,878"
Prostate Cancer,2009,NCI,5R01CA127873-02,,Androgen and Soluble Guanylyl Cyclase Signaling in Prostate Cancer,"SHEMSHEDINI, LIRIM",UNIVERSITY OF TOLEDO,OH,"$281,066"
Prostate Cancer,2009,NCI,5R01CA085142-10,,Glucocorticoids & Vitamin D: Role In Anti-Tumor Effects,"JOHNSON, CANDACE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$382,661"
Prostate Cancer,2009,NINR,5R01NR009692-04,,"Personal Patient Profile-Prostate (P4) Randomized, Multi-site Trial","WOLPIN, SETH",UNIVERSITY OF WASHINGTON,WA,"$154,994"
Prostate Cancer,2009,NCI,5K23CA122820-04,,In Vivo Efficacy of Multi-Targeted Androgen Inhibition as Prostate Cancer Therapy,"MOSTAGHEL, ELAHE",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$134,460"
Prostate Cancer,2009,NCI,7K01CA114313-04,,Ultrasonic Tissue-Typing-Guided Prostate Brachytherapy,"LIU, TIAN",EMORY UNIVERSITY,GA,"$156,546"
Prostate Cancer,2009,NCI,5R01CA084950-10,,Molecular Epidemiology of Prostate Cancer in Tobagonians,"BUNKER, CLAREANN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$462,777"
Prostate Cancer,2009,NCI,5U01CA128416-03,,Immunogenic sugar moieties of prostate cancers,"WANG, DENONG",STANFORD UNIVERSITY,CA,"$402,953"
Prostate Cancer,2009,NCI,5R01CA131013-02,,Multi-parametric MRI Determination of Prostate Cancer Aggressiveness and Extent,"METZGER, GREGORY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$313,325"
Prostate Cancer,2009,NCI,1K99CA138711-01,,Ligand-Independent Selective Modulation of Androgen Receptor Activity,"JONES, JEREMY",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$116,015"
Prostate Cancer,2009,NCI,1R21CA139108-01,,Sensitive biomarker detection using organized nanoparticles in multiwell plates,"WIRTH, MARY",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$196,575"
Prostate Cancer,2009,NIDDK,1K01DK083425-01,,Beta-Catenin and Prostate Development,"VEZINA, CHAD",UNIVERSITY OF WISCONSIN MADISON,WI,"$147,528"
Prostate Cancer,2009,NCI,5K01CA114033-04,,Identifying Metastasis-Suppressor Genes in Cancer,"YI, YAJUN",VANDERBILT UNIVERSITY,TN,"$152,739"
Prostate Cancer,2009,NCI,1R21CA139386-01,,High resolution spectroscopy for in vivo copper speciation in prostate and breast,"BARREA, RAUL",ILLINOIS INSTITUTE OF TECHNOLOGY,IL,"$182,352"
Prostate Cancer,2009,NIA,5R01AG025099-05,,Aromatase inhibition in elderly hypogonadal men,"LEDER, BENJAMIN",MASSACHUSETTS GENERAL HOSPITAL,MA,"$345,552"
Prostate Cancer,2009,NCI,5R21CA132267-02,,Pilot trial of a DNA vaccine encoding PAP in patients with prostate cancer,"MCNEEL, DOUGLAS",UNIVERSITY OF WISCONSIN MADISON,WI,"$294,739"
Prostate Cancer,2009,NCI,5R01CA091883-07,,Prostate Cancer Prevention by Procyanidins in Grape Seed Extract,"AGARWAL, CHAPLA",UNIVERSITY OF COLORADO DENVER,CO,"$333,644"
Prostate Cancer,2009,NCI,5R01CA118970-03,,BK Virus as a Co-Factor in Prostate Cancer,"IMPERIALE, MICHAEL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$284,829"
Prostate Cancer,2009,NCI,5R01CA092447-08,,Southern Community Cohort Study,"BLOT, WILLIAM",VANDERBILT UNIVERSITY,TN,"$5,747,185"
Prostate Cancer,2009,NCI,5K01CA114253-04,,Regulation of Prostate Cancer Growth by PPARg Ligands,"STEWART, LAMONICA",MEHARRY MEDICAL COLLEGE,TN,"$150,931"
Prostate Cancer,2009,NCI,5F31CA123754-03,,"Characterization of G Protein, Rap1, and its Role in Prostate Cancer","HENDERSON, VERONICA",EMORY UNIVERSITY,GA,"$28,938"
Prostate Cancer,2009,NCI,5R01CA122840-03,,Loss of Androgen Receptor Promotes Metastatic Prostate Cancer,"CHANG, CHAWNSHANG",UNIVERSITY OF ROCHESTER,NY,"$292,600"
Prostate Cancer,2009,NCI,5R21CA125909-02,,Soy Almond Bread as Complimentary Therapy for Prostate Cancer,"VODOVOTZ, YAEL",OHIO STATE UNIVERSITY,OH,"$202,500"
Prostate Cancer,2009,NCI,5R01CA088164-09,,Genetic Epidemiology of Prostate Cancer Aggressiveness,"WITTE, JOHN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$496,160"
Prostate Cancer,2009,NCI,5R01CA060872-12,,Mechanism of Apoptosis and Inhibition of Tumor Progression and Metastasis by Par-,"RANGNEKAR, VIVEK",UNIVERSITY OF KENTUCKY,KY,"$302,065"
Prostate Cancer,2009,NCI,5R01CA115801-03,,Redox Modulation of Prostate Cancer,"ST CLAIR, WILLIAM",UNIVERSITY OF KENTUCKY,KY,"$250,538"
Prostate Cancer,2009,NCI,7R01CA114524-03,,"Race, Comorbidity & Long Term Prostate Cancer Outcomes","PENSON, DAVID",VANDERBILT UNIVERSITY,TN,"$572,771"
Prostate Cancer,2009,NCI,5R01CA119092-02,,Hyaluronan Receptors in Prostate Cancer Progression,"MCCARTHY, JAMES",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$471,291"
Prostate Cancer,2009,NIBIB,5K08EB003647-05,,Development of Disease-Specific Drug Delivery Vehicles,"FAROKHZAD, OMID",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$192,888"
Prostate Cancer,2009,NCI,5K07CA106730-05,,Prostate cancer and genes of the one-carbon cycle,"ZEIGLER-JOHNSON, CHARNITA",UNIVERSITY OF PENNSYLVANIA,PA,"$138,671"
Prostate Cancer,2009,NCI,2R01CA097131-06A2,,Modulation of IGF-II Imprinting in the Aging Prostate,"JARRARD, DAVID",UNIVERSITY OF WISCONSIN MADISON,WI,"$265,727"
Prostate Cancer,2009,NCI,5F32CA125955-02,,Deregulated Wnt Signaling in Prostate Cancer,"HOUGHTALING, SCOTT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$27,106"
Prostate Cancer,2009,NCI,5R01CA123199-03,,Stromal androgen receptors mediated human prostate Cancer progression,"RICKE, WILLIAM",UNIVERSITY OF ROCHESTER,NY,"$292,600"
Prostate Cancer,2009,NIDDK,5R01DK040890-19,,Development Estrogenization of the Rat Prostate Gland,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$339,439"
Prostate Cancer,2009,NCI,5K01CA123532-04,,"Identification, Isolation and Characterization of Prostate Cancer Stem Cells","ZHAO, HONGJUAN",STANFORD UNIVERSITY,CA,"$122,473"
Prostate Cancer,2009,NCI,1R01CA134530-01A1,,The Par-4/PKCz complex in prostate cancer,"DIAZ-MECO, MARIA",UNIVERSITY OF CINCINNATI,OH,"$325,084"
Prostate Cancer,2009,NCI,1R01CA133209-01A1,,Rapamycin Regulation of the Androgen Receptor: Implications in Prostate Cancer,"GHOSH, PARAMITA",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$235,305"
Prostate Cancer,2009,NCI,2R01CA075080-11A1,,"Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB","BALDWIN JR, ALBERT",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$304,118"
Prostate Cancer,2009,NCI,2R01CA096824-06A2,,FRS2-mediated Signals in Prostatic Tumorigenesis and Development,"WANG, FEN",TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR,TX,"$254,676"
Prostate Cancer,2009,NIDDK,2R01DK055748-10A1,,Control of Prostate-Specific Gene Expression,"MATUSIK, ROBERT",VANDERBILT UNIVERSITY,TN,"$371,100"
Prostate Cancer,2009,NCI,1R01CA134675-01A1,,PSMA-based Cancer Imaging Agents,"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$319,733"
Prostate Cancer,2009,NCI,5R01CA125612-03,,Towards Understanding Prostate Cancer Heterogeneity,"RUBIN, MARK",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$365,372"
Prostate Cancer,2009,NCI,5R01CA112517-05,,Genetic Susceptibility for Prostate Cancer Progression,"ISAACS, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$324,119"
Prostate Cancer,2009,NCI,2R01CA086072-07A2,,Androgen Receptor Function in Prostate Cancer,"PESTELL, RICHARD",THOMAS JEFFERSON UNIVERSITY,PA,"$320,588"
Prostate Cancer,2009,NIBIB,2R01EB003730-05,,Assembly of phi29 pRNA nanoparticles for siRNA delivery to prostate cancer cells,"GUO, PEIXUAN",UNIVERSITY OF CINCINNATI,OH,"$298,065"
Prostate Cancer,2009,NCI,1R01CA133009-01A2,,Genetics Variants in the Genome Predisposing to Aggressive PCa,"ISAACS, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$637,540"
Prostate Cancer,2009,NCI,1R01CA122602-01A2,,Beta 2-Microglobulin signaling and targeting in bone metastasis,"CHUNG, LELAND",CEDARS-SINAI MEDICAL CENTER,CA,"$303,469"
Prostate Cancer,2009,NCI,2R01CA101992-05A1,,Mechanisms of Action and Signaling by Steroid Hormone Antagonists,"FALLER, DOUGLAS",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$260,271"
Prostate Cancer,2009,NCI,5R01CA130916-02,,Role of Dystroglycan in Prostate Cancer Progression,"HENRY, MICHAEL",UNIVERSITY OF IOWA,IA,"$343,146"
Prostate Cancer,2009,NCI,1R01CA136753-01A1,,Prostate Cancer Immunotherapy,"FONG, LAWRENCE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$320,588"
Prostate Cancer,2009,NCI,7R01CA118037-04,,Image-guided radiation therapy of prostate cancer,"WU, QIUWEN",DUKE UNIVERSITY,NC,"$225,346"
Prostate Cancer,2009,NIDDK,5R01DK076602-05,,Progenitor cells of the mouse prostate epithelium,"SHEN, MICHAEL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$314,069"
Prostate Cancer,2009,NCI,1R01CA135087-01A1,,Glycan Biomarkers of Prostate Cancer in Prostatic Fluids,"DRAKE, RICHARD",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$252,631"
Prostate Cancer,2009,NIA,5K23AG027238-04,,Hormonal and molecular consequences of androgen replacement on the prostate,"PAGE, STEPHANIE",UNIVERSITY OF WASHINGTON,WA,"$126,792"
Prostate Cancer,2009,NCI,1R03CA139489-01,,Metabolomic Markers for Early Detection of Prostate Cancer,"SREEKUMAR, ARUN",MEDICAL COLLEGE OF GEORGIA (MCG),GA,"$73,500"
Prostate Cancer,2009,NCI,5R01CA121191-04,,Reversal of regulatory T cell function in prostate cancer,"WANG, RONGFU",BAYLOR COLLEGE OF MEDICINE,TX,"$258,529"
Prostate Cancer,2009,NCI,5R01CA128813-02,,Genetic & epigenetic analysis of angiogenesis genes in recurrent prostate cancer,"PARK, JONG",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$628,729"
Prostate Cancer,2009,NCI,5R01CA114104-04,,Fatty acid synthase inhibitors and prostate cancer,"KRIDEL, STEVEN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$247,327"
Prostate Cancer,2009,NCI,5R01CA127541-02,,Drug Development of Ribonucleotide Reductase Inhibitor,"YEN, YUN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$344,450"
Prostate Cancer,2009,NIBIB,5R01EB007171-05,,Polymers for Targeted Delivery of Angiogenic Inhibitors,"GHANDEHARI, HAMID",UNIVERSITY OF UTAH,UT,"$297,654"
Prostate Cancer,2009,NCI,5U01CA098710-06,,Characterizing Genetic Susceptibility to Breast and Prostate Cancer: The BPC3.,"THUN, MICHAEL","AMERICAN CANCER SOCIETY, INC.",GA,"$550,218"
Prostate Cancer,2009,NCI,5U01CA098233-07,,Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3,"HUNTER, DAVID",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$1,403,224"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,8686,Prostate Cancer Induces CCL2 Expression and Transforms the Bone Microenvi,"PIENTA, KENNETH",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$233,843"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,8687,"Prostate Cancer Parasitism of the HSC ""niche"" as a Molecular Mechanism for Ost","TAICHMAN, RUSSELL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$221,716"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,8688,DKK as a Key Regulator of Prostate Cancer Bone Metastasis,"KELLER, EVAN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$231,641"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,8689,"PTHrP, Osteoblasts and Hematopoietic Cells in the Sketletal Metastic Niche","MCCAULEY, LAURIE",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$202,653"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,8690,Administrative Core,"KELLER, EVAN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$165,835"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,8691,Animal Core,"KELLER, EVAN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$338,518"
Prostate Cancer,2009,NCI,1R21CA131702-01A2,,Alpha Methyl AcylCoa Racemase (AMACR),"POMPER, MARTIN",JOHNS HOPKINS UNIVERSITY,MD,"$216,480"
Prostate Cancer,2009,NCI,2R01CA058033-16A2,,CD24 in Cancer Resistance and Immunotherapy,"LIU, YANG",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$292,144"
Prostate Cancer,2009,NCI,5R01CA127729-02,,The influence of selenium on biomarkers of prostate cancer risk,"EL-BAYOUMY, KARAM",PENNSYLVANIA STATE UNIV HERSHEY MED CTR,PA,"$428,977"
Prostate Cancer,2009,NCI,1K22CA133105-01A2,,Significance of Vitamin D-Regulated MicroRNAs in Prostate Cancer Prevention,"NONN, LARISA",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$162,731"
Prostate Cancer,2009,NCRR,1K01RR025161-01A1,,Development of Nonhuman Primate Models for PSA Biology Studies,"MUBIRU, JAMES",SOUTHWEST FOUNDATION FOR BIOMEDICAL RES,TX,"$91,851"
Prostate Cancer,2009,NCI,5U01CA102532-05,,DNA-DIRECTED EFFECTS OF FdUMP(N),"GMEINER, WILLIAM",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$300,196"
Prostate Cancer,2009,NCI,5F31CA123703-04,,Identification of Prostate Stem Cells in the Mouse,"SCOTLAND, KYMORA",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$44,689"
Prostate Cancer,2009,NCI,5F32CA119642-03,,Mechanism(s) of AR gene repression in prostate cancer,"WITTMANN, BRYAN",DUKE UNIVERSITY,NC,"$55,310"
Prostate Cancer,2009,NCI,1R21CA137518-01A1,,SIRT1 as a Resveratrol target in PTEN knockout Prostate Cancer Model,"KUMAR, ADDANKI",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$187,246"
Prostate Cancer,2009,NCI,5R01CA129003-03,,"Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models","ALBANESE, CHRISTOPHER",GEORGETOWN UNIVERSITY,DC,"$291,650"
Prostate Cancer,2009,NCI,5R01CA129356-03,,18F-FACBC PET-CT for the Detection and Staging of Recurrent Prostate Carcinoma,"SCHUSTER, DAVID",EMORY UNIVERSITY,GA,"$343,987"
Prostate Cancer,2009,NCI,5K01CA131500-02,,Life After Cancer: Examining Survivor Transitions From Specialist to Primary Care,"HUDSON, SHAWNA",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$125,956"
Prostate Cancer,2009,NCI,5R01CA118329-02,,Stress-activated signaling in prostate cancer,"KULIK, GEORGE",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$311,148"
Prostate Cancer,2009,NCI,1R03CA136027-01A1,,Hormonal Induction Mouse Models of Prostate Cancer,"BOSLAND, MAARTEN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$78,500"
Prostate Cancer,2009,NCI,2R01CA102365-06,,Invasion and Metastasis in Prostate Cancer,"VASIOUKHIN, VALERI",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$317,129"
Prostate Cancer,2009,NCI,5K23CA115775-05,,Targeting Androgen -IGF Interactions in Prostate Cancer,"RYAN, CHARLES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$128,762"
Prostate Cancer,2009,NCI,5R01CA116399-04,,Evaluation of Palliative Prostate Cancer Among Elderly Men,"LU-YAO, GRACE",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$143,440"
Prostate Cancer,2009,NCI,2R01CA102514-06,,Prostate Cancer Prevention and Treatment by Silibinin,"AGARWAL, RAJESH",UNIVERSITY OF COLORADO DENVER,CO,"$334,007"
Prostate Cancer,2009,NCI,5R01CA124650-03,,Mechanism of tumor metastases suppression by Drg1,"WATABE, KOUNOSUKE",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$202,300"
Prostate Cancer,2009,NCI,5R01CA059705-17,,PATHOGENESIS AND PROGRESSION OF PROSTATE CANCER,"ROY-BURMAN, PRADIP",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$569,079"
Prostate Cancer,2009,NCI,5R01CA124706-02,,Role of Androgen Receptor Phosphorylation in Prostate Cancer,"GIOELI, DANIEL",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$343,098"
Prostate Cancer,2009,NCI,5R01CA088184-09,,Signaling in Androgen-Refractory Prostate Cancer,"LIN, MING-FONG",UNIVERSITY OF NEBRASKA MEDICAL CENTER,NE,"$245,375"
Prostate Cancer,2009,NCI,5R01CA116465-04,,Characterization of Prostate Cancer with 3T MR,"ROFSKY, NEIL",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$371,857"
Prostate Cancer,2009,NCI,5R01CA119007-04,,PHSCN Therapies to Prevent Prostate Cancer Progression,"LIVANT, DONNA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$261,260"
Prostate Cancer,2009,NCI,5R01CA130948-02,,Mechanisms of Triterpenoids in Prevention of Prostate Cancer,"GAUTAM, SUBHASH",HENRY FORD HEALTH SYSTEM,MI,"$300,875"
Prostate Cancer,2009,NCI,5U01CA098758-07,,Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3,"HENDERSON, BRIAN",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$645,626"
Prostate Cancer,2009,NCI,5K07CA129162-02,,Pathway Modeling of Complex Toxin Response and Energy Balance Systems in Cancer,"NOCK, NORA",CASE WESTERN RESERVE UNIVERSITY,OH,"$126,065"
Prostate Cancer,2009,NCI,5K99CA131472-02,,"Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate Cancer","DI VIZIO, DOLORES",CHILDREN'S HOSPITAL BOSTON,MA,"$136,647"
Prostate Cancer,2009,NCI,5R44CA126441-03,,Early Screening of Breast Lesion Trial (Phase III Pivotal),"BENARON, DAVID",SPECTROS CORPORATION,CA,"$701,169"
Prostate Cancer,2009,NCI,5R33CA132022-02,,Molecular Analysis of Steroid Hormone Receptors with X-ray Crystallography,"NETTLES, KENDALL",SCRIPPS RESEARCH INSTITUTE,CA,"$401,629"
Prostate Cancer,2009,NCI,5R01CA115484-05,,CaP Metastasis Biomarkers: Validation/Genomics/Biology,"PARIS, PAMELA",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$283,708"
Prostate Cancer,2009,NCI,5R01CA096823-07,,Determinants of Metastatic Progression,"NIKITIN, ALEXANDER",CORNELL UNIVERSITY ITHACA,NY,"$270,128"
Prostate Cancer,2009,NCI,5R01CA123175-03,,mTOR Therapy in Prostate Cancer: Signatures of Response and Biology of Resistance,"FEBBO, PHILLIP",DUKE UNIVERSITY,NC,"$308,811"
Prostate Cancer,2009,NCI,5R01CA118918-04,,The fuel sensing enzyme AMPK in the pathogenesis of prostate cancer,"LUO, ZHIJUN",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$224,058"
Prostate Cancer,2009,NCI,5R01CA115746-04,,Characterizing Prostate Cancer By ex vivo MRS Signatures,"CHENG, LEO",MASSACHUSETTS GENERAL HOSPITAL,MA,"$564,008"
Prostate Cancer,2009,NCI,5R01CA121277-08,,Coregulators in Androgen-Refractory Prostate Cancer,"TINDALL, DONALD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$264,063"
Prostate Cancer,2009,NCI,5R01CA111291-04,,"Morphologic, Metabolic and Functional Prostate Imaging","VIGNERON, DANIEL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$461,869"
Prostate Cancer,2009,NIBIB,5R01CA111291-04,,"Morphologic, Metabolic and Functional Prostate Imaging","VIGNERON, DANIEL",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$392,822"
Prostate Cancer,2009,NCI,5R43CA133987-02,,Single Molecule Fiber Arrays for the Detection of Low Abundance Proteins,"DUFFY, DAVID",QUANTERIX CORPORATION,MA,"$51,314"
Prostate Cancer,2009,NCI,5R01CA128158-13,,Roles of Mouse GLI Genes in Hedgehog Signaling,"JOYNER, ALEXANDRA",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$499,277"
Prostate Cancer,2009,NCI,5R21CA135463-02,,Chemoaffinity Agents For Capturing Prostate Cancer Cells,"BERKMAN, CLIFFORD",WASHINGTON STATE UNIVERSITY,WA,"$162,581"
Prostate Cancer,2009,NIA,5SC1AG033407-02,,Role of Follistatin during Androgen Regulation of Body Composition,"SINGH, RAJAN",CHARLES R. DREW UNIVERSITY OF MED & SCI,CA,"$282,000"
Prostate Cancer,2009,NCI,5R01CA131445-02,,15-Lipoxygenase-2 (ALOX15B) as a Tumor Suppressor,"NIE, DAOTAI",SOUTHERN ILLINOIS UNIVERSITY SCH OF MED,IL,"$221,524"
Prostate Cancer,2009,NCI,5R01CA106947-04,,Prostate Microenvironmental & Prostate Cancer Progression,"CHAN, JUNE",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$259,572"
Prostate Cancer,2009,NCI,5R03CA136055-02,,Thiroredoxin Targeted Nanoparticles for Cancer Research,"SMITH, STEVEN",CITY OF HOPE/BECKMAN RESEARCH INSTITUTE,CA,"$83,000"
Prostate Cancer,2009,NCI,5U01CA098216-06,,Characterizing Genetic Susceptibility to Breast and Prostate Cancer; the BPC3,"RIBOLI, ELIO",U OF L IMPERIAL COL OF SCI/TECHNLGY/MED,UK,"$985,556"
Prostate Cancer,2009,NCI,5U01CA114810-05,,Evaluation of Predictive Signatures of Prostate Cancer,"MERCOLA, DAN",UNIVERSITY OF CALIFORNIA IRVINE,CA,"$1,443,611"
Prostate Cancer,2009,NCI,5R21CA121586-02,,MRI Guided and Tumor Targeted HDR Brachytherapy for Recurrent Prostate Cancer,"MENARD, CYNTHIA",UNIVERSITY HEALTH NETWORK,CANADA,"$127,111"
Prostate Cancer,2009,NCI,5R01CA085560-09,,Identification and characterization of tumor suppressor genes in prostate cancer,"DONG, JIN-TANG",EMORY UNIVERSITY,GA,"$222,845"
Prostate Cancer,2009,NCI,5R01CA125384-03,,"Tomatoes, Lycopene, and Prostate Carcinogenesis in Mice","ERDMAN, JOHN",UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,IL,"$287,289"
Prostate Cancer,2009,NCI,5R01CA121060-03,,Genetic and Endocrine Pathways Linking Obesity with Prostate Cancer,"FOWKE, JAY",VANDERBILT UNIVERSITY,TN,"$571,978"
Prostate Cancer,2009,NIDDK,5R01DK081841-02,,PTEN- and EGFR-Dependence of CXCL12-Mediated Proliferation in the Aging Prostate,"MACOSKA, JILL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$328,313"
Prostate Cancer,2009,NCI,5U10CA074811-12,,Minority Based Community Clinical Oncology Program,"PEACE, DAVID",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$819,197"
Prostate Cancer,2009,NCI,2R01CA099996-07A2,,Cyclin D1: repercussions of AR control and alternative splicing in prostate cance,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$268,407"
Prostate Cancer,2009,NCI,5U10CA095867-08,,"Stroger Hospital of Cook County, Department of Surgery,*","LAD, THOMAS",HEKTOEN INSTITUTE FOR MEDICAL RESEARCH,IL,"$699,027"
Prostate Cancer,2009,NCCAM,5R01AT003544-03,,Antitumor and chemopreventive activity of the Ecuadorian plant extract BIRM,"LOKESHWAR, BALAKRISHNA",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$296,881"
Prostate Cancer,2009,NCI,5R01CA130536-15,,Mechanisms of Radioresistance and Cell Cycle Progression,"LIEBERMAN, HOWARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$360,812"
Prostate Cancer,2009,NCI,5R01CA132641-12,,The Biology of Prostate Stem Cells,"WILSON, E",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$403,422"
Prostate Cancer,2009,NCI,1R43CA134041-01A1,,Diagnostic IgM and IgA Autoantibodies for Prostate Cancer,"KLINGER, MARTIN","VIVO BIOSCIENCES, INC.",AL,"$171,654"
Prostate Cancer,2009,NCI,5R01CA126880-03,,Methyl-selenium for prostate cancer chemoprevention,"LU, JUNXUAN",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$286,900"
Prostate Cancer,2009,NCI,5K01CA116002-05,,Modeling MIC Shedding in Prostate Cancer Progression,"WU, JENNIFER",UNIVERSITY OF WASHINGTON,WA,"$153,306"
Prostate Cancer,2009,NCI,5F32CA132358-02,,SIRT1 attenuates beta-catenin mediated tumorigenesis,"BELL, ERIC",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$47,210"
Prostate Cancer,2009,NCI,5R01CA134579-02,,Imaging Feedback to Guide Ultrasonic Tissue Fractionation for Cancer Therapy,"CAIN, CHARLES",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$537,768"
Prostate Cancer,2009,NCI,5K07CA119109-03,,"Oxidative Stress, Antioxidants and Racial Disparities in Prostate Cancer","BOCK, CATHRYN",WAYNE STATE UNIVERSITY,MI,"$132,921"
Prostate Cancer,2009,NCI,5R01CA111470-04,,Genistein and Prostate Cancer,"DAHIYA, RAJVIR",NORTHERN CALIFORNIA INSTITUTE RES & EDUC,CA,"$271,628"
Prostate Cancer,2009,NCI,5R01CA111842-05,,Targets for selenium in prostate cancer prevention,"PINTO, JOHN",NEW YORK MEDICAL COLLEGE,NY,"$290,071"
Prostate Cancer,2009,NCI,1R43CA139678-01,,Dual Integrin and GRPR Targeted Radiotherapy of Prostate Cancer,"WU, JENNY","ACADUCEUS PHARMACEUTICS, INC.",CA,"$100,000"
Prostate Cancer,2009,NCI,5R43CA134062-02,,Viability Pathway Models in Prostate Cancer Cells,"CHENCHIK, ALEX","CELLECTA, INC.",CA,"$151,643"
Prostate Cancer,2009,NCI,5R01CA130039-02,,Equol and Regulation of Prostate Growth,"HANDA, ROBERT",UNIVERSITY OF ARIZONA,AZ,"$314,811"
Prostate Cancer,2009,NIGMS,5SC3GM084769-02,,Identification of Prostate Cancer Stage in Hispanics Using Serum Protein Profile,"IRIZARRY-RAMIREZ, MARGARITA",UNIVERSITY OF PUERTO RICO MED SCIENCES,PR,"$112,500"
Prostate Cancer,2009,NCI,5R01CA094069-08,,"""Statistical Methods for Genetic Epidemiology""","WHITTEMORE, ALICE",STANFORD UNIVERSITY,CA,"$573,074"
Prostate Cancer,2009,NCI,1R43CA143232-01A1,,A Nanotechnology Enabled Point of Care Diagnostic Platform for Early Stage Cancer,"NELSON, JAMES","INANOVATE, INC.",NC,"$199,156"
Prostate Cancer,2009,NCI,5R44CA121661-03,,HIFU and Immunotherapy Treatment of Metastatic Prostate Cancer,"SANGHVI, NARENDRA","FOCUS SURGERY, INC.",IN,"$357,671"
Prostate Cancer,2009,NCI,5R01CA125192-04,,Analysis of the STAT3 Pathway In Tumor Tolerance and Immune Evasion,"PARDOLL, DREW",JOHNS HOPKINS UNIVERSITY,MD,"$282,659"
Prostate Cancer,2009,NCI,1R21CA139687-01,,Treatment Effects on Tumor 18F-Choline Metabolism in Advanced Prostate Cancer,"KWEE, SANDI",QUEEN'S MEDICAL CENTER,HI,"$383,240"
Prostate Cancer,2009,NIDDK,1F30DK083899-01,,Small-Molecule Disruptors of the Nuclear Hormone Receptor/Coactivator Interaction,"PARENT, ALEXANDER",UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,IL,"$46,176"
Prostate Cancer,2009,NCRR,5R00RR024366-03,,Activity-based selections and amplification of non-natural protease substrates,"SOELLNER, MATTHEW",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$249,000"
Prostate Cancer,2009,NCI,5R01CA116195-05,,ADJUVANT TRIAL WITH SOY AFTER RADICAL PROSTATECTOMY,"BOSLAND, MAARTEN",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$245,369"
Prostate Cancer,2009,NCI,5R01CA134330-02,,Clot formation in the tumor stroma as a target for prostate cancer treatment,"PILCH, JAN",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$314,363"
Prostate Cancer,2009,NCI,5R25CA114101-04,,Epidemiologic and Basic Science in Cancer Prevention,"MARSHALL, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$344,013"
Prostate Cancer,2009,NIDDK,5R01DK078243-03,,Modeling androgen receptor in prostate cells,"KUNG, HSING-JIEN",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$305,368"
Prostate Cancer,2009,NIEHS,5R37ES001332-34,,REPRODUCTIVE AND DEVELOPMENTAL TOXICITY OF DIOXIN,"PETERSON, RICHARD",UNIVERSITY OF WISCONSIN MADISON,WI,"$426,544"
Prostate Cancer,2009,NIBIB,5R01EB008275-04,,Multiplexed Nanosensing for DNA and Proteins,"COTE, RICHARD",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$620,767"
Prostate Cancer,2009,NCI,5K01CA122183-04,,Sleeping Beauty for cancer gene discovery,"COLLIER, LARA",UNIVERSITY OF WISCONSIN MADISON,WI,"$166,185"
Prostate Cancer,2009,NIDDK,5R21DK080483-02,,Cytokines Stimulate Prostate Epithelial Proliferation,"BUSHMAN, WADE",UNIVERSITY OF WISCONSIN MADISON,WI,"$222,750"
Prostate Cancer,2009,NIGMS,5R01GM064560-08,,Molecular Recognition in Dendrimers Based on Melamine,"SIMANEK, ERIC",TEXAS A&M UNIVERSITY SYSTEM,TX,"$245,238"
Prostate Cancer,2009,NCI,5R01CA114051-04,,Role of Thromboxane in Prostate Cancer Progression,"HONN, KENNETH",WAYNE STATE UNIVERSITY,MI,"$282,215"
Prostate Cancer,2009,NCI,5R01CA121460-04,,A Serum Marker for Aggressive Prostate Cancer,"PEEHL, DONNA",STANFORD UNIVERSITY,CA,"$439,850"
Prostate Cancer,2009,NCCAM,5R01AT002978-04,,Phytoestrogen and Antioxidant Regulation of Prostate Cancer,"LUBAHN, DENNIS",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$281,063"
Prostate Cancer,2009,NCCAM,5R01AT002709-05,,Chamomile as  Medicine for Prostate cancer,"GUPTA, SANJAY",CASE WESTERN RESERVE UNIVERSITY,OH,"$260,220"
Prostate Cancer,2009,NCCAM,5K23AT002965-05,,Diet and Stress Reduction in Recurrent Prostate Cancer,"SAXE, GORDON",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$121,770"
Prostate Cancer,2009,NCI,5R01CA114412-04,,Ethnicity & Determinants of QoL Following PCa Treatment,"PENEDO, FRANK",UNIVERSITY OF MIAMI CORAL GABLES,FL,"$126,797"
Prostate Cancer,2009,NCI,5R01CA119412-05,,Hybrid Nanoparticles in Imaging and Therapy of Prostate*,"KATTI, KATTESH",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$576,101"
Prostate Cancer,2009,NCI,5U01CA097414-09,,Population Impact of Cancer Control Processes,"TSODIKOV, ALEXANDER",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$204,754"
Prostate Cancer,2009,NCI,5R01CA115555-03,,DNA Damage-Response Defects in Prostate Cancer Risk,"LIU, WANGUO",LOUISIANA STATE UNIV HSC NEW ORLEANS,LA,"$320,798"
Prostate Cancer,2009,NIBIB,5R41EB008907-02,,A Novel Nanomaterials Approach for Cancer Imaging and Therapeutic Treatment,"NAHA, SAYANGDEV","ADA TECHNOLOGIES, INC.",CO,"$150,688"
Prostate Cancer,2009,NIGMS,5R01GM084933-02,,Selection of Boronic Acid-modified Aptamers for Glycoproteins,"WANG, BINGHE",GEORGIA STATE UNIVERSITY,GA,"$290,400"
Prostate Cancer,2009,NCI,5U10CA037429-25,,"CCOP Research Base, PCPT/PCPT LTFU, and SELECT Programs","BAKER, LAURENCE",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$10,708,109"
Prostate Cancer,2009,NCI,5U01CA088160-09,,"Modeling US Prostate Cancer Trends: PSA, Treatment & Ra*","ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$143,611"
Prostate Cancer,2009,NCMHD,1T37MD003399-01,,Shaw in Jamaica MoN Project,"HOWARD, DANIEL",SHAW UNIVERSITY,NC,"$241,848"
Prostate Cancer,2009,NCI,5R01CA118682-03,,The Functions of Affect in Treatment Decisions of Rising PSA Patients,"DIEFENBACH, MICHAEL",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$190,393"
Prostate Cancer,2009,NIEHS,5K99ES016817-02,,Estrogens/Xenoestrogens and Epigenetic Regulation of Gene Expression,"TANG, WAN-YEE",UNIVERSITY OF CINCINNATI,OH,"$90,000"
Prostate Cancer,2009,NCI,5R01CA126596-03,,A Sustainable Approach to Increasing Cancer Screening in Community Health Centers,"EMMONS, KAREN",DANA-FARBER CANCER INSTITUTE,MA,"$588,226"
Prostate Cancer,2009,NCI,5R01CA085074-09,,Ethnic difference in prostate cancer,"REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$252,110"
Prostate Cancer,2009,NCI,5K01CA125204-04,,Improving Effectiveness and Accuracy of Radiation Therapy,"HOWELL, REBECCA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$133,622"
Prostate Cancer,2009,NCI,5R01CA127548-02,,"TR4 orphan receptor, a longevity assurance gene, in prostate carcinogenesis","LEE, YI-FEN",UNIVERSITY OF ROCHESTER,NY,"$270,001"
Prostate Cancer,2009,NCI,5R01CA129435-03,,Fine mapping and characterization of the 8q24 prostate cancer risk locus,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$447,130"
Prostate Cancer,2009,NCI,5R01CA129991-03,,Focused Genomic Dissection of the Prostate Cancer Risk Variant on Chromosome 8q24,"STEFANSSON, KARI","DECODE GENETICS, INC.",ICELAN,"$196,509"
Prostate Cancer,2009,NCI,5R01CA118755-02,,"Tumor microenvironment, tissue liquidity, and cell interaction in prostate cancer","FOTY, RAMSEY",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$323,700"
Prostate Cancer,2009,NCI,5R01CA131874-02,,Outcomes Based Guideline Development for Prostate Cancer Screening and Treatment,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$286,623"
Prostate Cancer,2009,NCI,5R01CA112226-02,,An androgen receptor coactivator regulated in prostate,"LOGAN, SUSAN",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$351,713"
Prostate Cancer,2009,NCI,5R01CA084176-07,,The therapeutic potential of maspin in prostate cancer,"SHENG, SHIJIE",WAYNE STATE UNIVERSITY,MI,"$261,975"
Prostate Cancer,2009,NCCAM,5R21AT004514-02,,Sweet gum extract and late stage prostate cancer,"YANG, PEIYING",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$227,508"
Prostate Cancer,2009,NCI,5U01CA116875-05,,Chicago Cancer Navigation Project,"ROSEN, STEVEN",NORTHWESTERN UNIVERSITY,IL,"$655,253"
Prostate Cancer,2009,NCI,5R01CA134627-02,,Prostate Edema in Permanent Interstitial Brachytherapy,"CHEN, ZHE",YALE UNIVERSITY,CT,"$270,000"
Prostate Cancer,2009,NCI,5R01CA125379-02,,The Ron Receptor/Chemokine Axis in Prostate Cancer,"WALTZ, SUSAN",UNIVERSITY OF CINCINNATI,OH,"$323,700"
Prostate Cancer,2009,NCI,5R03CA136023-02,,Dietary Intervention for Bisphenol A-induced Susceptibility to Prostate Neoplasia,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$78,500"
Prostate Cancer,2009,NCI,5R33CA126663-02,,Integration of Vascular Genomics and Proteomics for Diagnosis and Therapy of Canc,"PASQUALINI, RENATA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$340,506"
Prostate Cancer,2009,NCI,5R01CA131137-02,,A Novel Synthetic Androgen Receptor Antagonist,"DONG, ZHONGYUN",UNIVERSITY OF CINCINNATI,OH,"$323,700"
Prostate Cancer,2009,NCI,5R44CA134158-02,,Beta Camera and Laparoscopic Probe for Surgical Cancer Removal.,"DAGHIGHIAN, FARHAD","INTRA MEDICAL IMAGING, LLC",CA,"$281,199"
Prostate Cancer,2009,NCI,5K08CA118428-04,,Molecular actions of tumor-derived endothelin-1 in the bone microenvironment,"CLINES, GREGORY",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$136,323"
Prostate Cancer,2009,NCI,5R01CA131235-02,,"Resveratrol, Carbohydrate Restriction and Prostate Cancer Progression","FREEDLAND, STEPHEN",DUKE UNIVERSITY,NC,"$309,798"
Prostate Cancer,2009,NCI,5R01CA135405-02,,Transition State Analogues as Modulators of DNA Methylation,"SCHRAMM, VERN",ALBERT EINSTEIN COL OF MED YESHIVA UNIV,NY,"$270,000"
Prostate Cancer,2009,NCI,5R01CA134964-02,,Determinants and risks of use and overuse of expensive oncology drugs,"HERSHMAN, DAWN",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$259,686"
Prostate Cancer,2009,NCI,5R03CA133902-02,,"Prevention of prostate cancer by Lipitor, Celebrex and voluntary exercise","ZHENG, XI",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$77,250"
Prostate Cancer,2009,NCI,5K99CA131489-02,,"Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent","ANEJA, RITU",GEORGIA STATE UNIVERSITY,GA,"$132,965"
Prostate Cancer,2009,NCI,5U24CA126480-04,,APT: the Analytical Proteomics Team,"REGNIER, FRED",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$1,093,652"
Prostate Cancer,2009,NCI,5R01CA089406-08,,Regulation of cancer cell-cycle by statins,"DUTTA, ANINDYA",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$230,751"
Prostate Cancer,2009,NCI,5R01CA133475-03,,Novel adamantyl arotinoids for the prevention and treatment of prostate cancer,"PIEDRAFITA, F",TORREY PINES INST FOR MOLECULAR STUDIES,CA,"$239,857"
Prostate Cancer,2009,NIEHS,5R01ES016675-09,,Endocrine disruptors: AR regulation and prostate cancer,"KNUDSEN, KAREN",THOMAS JEFFERSON UNIVERSITY,PA,"$374,471"
Prostate Cancer,2009,NCI,5R03CA137799-02,,Estrogen Pathway Genes and Association with Prostate Cancer Risk,"STANFORD, JANET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$88,000"
Prostate Cancer,2009,NCI,5R01CA095045-07,,Vitamin D in Prostate Cancer:  Tumor Vasculature Effects,"JOHNSON, CANDACE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$273,560"
Prostate Cancer,2009,NCI,5U24CA126485-04,,Assessment of serum peptide profiling to detect cancer-specific patterns,"TEMPST, PAUL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$1,417,183"
Prostate Cancer,2009,NCI,5K99CA137147-02,,Design and Evaluation of Hypoxia Enhanced Bombesin Analogs for Prostate Cancer,"GARRISON, JERED",UNIVERSITY OF MISSOURI-COLUMBIA,MO,"$99,408"
Prostate Cancer,2009,NCI,5U01CA127298-02,,Genomewide Association Study of Prostate Cancer,"WITTE, JOHN",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$1,148,946"
Prostate Cancer,2009,NHGRI,5U01HG004726-02,,A Multiethnic Genome-Wide Scan of Prostate Cancer,"HAIMAN, CHRISTOPHER",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$629,234"
Prostate Cancer,2009,NCI,5R01CA122985-02,,Genistein-mediated Regulation of Prostate Cancer Cell Motility,"BERGAN, RAYMOND",NORTHWESTERN UNIVERSITY,IL,"$319,357"
Prostate Cancer,2009,NCI,5P20CA138018-02,,North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2),"AKMAN, STEVEN",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$103,226"
Prostate Cancer,2009,NCI,5R01CA125395-03,,Roles of Nemo-like kinase in CaP and its effects on androgen receptor signaling,"COREY, EVA",UNIVERSITY OF WASHINGTON,WA,"$237,120"
Prostate Cancer,2009,NCI,5P20CA138020-02,,North Carolina A&T University-Wake Forest Cancer Center partnership (1of 2),"SMITH, MARY",NORTH CAROLINA AGRI & TECH ST UNIV,NC,"$284,290"
Prostate Cancer,2009,NIGMS,5F31GM079879-03,,TGF-Beta and Androgen Signaling During Prostate Regression,"PLACENCIO, VERONICA",VANDERBILT UNIVERSITY,TN,"$40,972"
Prostate Cancer,2009,NCI,5U01CA089600-07,,Prostate Cancer Susceptibility: The ICPCG Study,"ISAACS, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$2,358,806"
Prostate Cancer,2009,NCI,5R01CA116379-02,,3-D Transrectal Ultrasound with 2-D Arrays,"YEN, JESSE",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$248,041"
Prostate Cancer,2009,NCI,5R21CA129775-02,,Deformable mapping of MRI and MRSI data to TRUS images to guide prostate biopsy,"PIZER, STEPHEN",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$164,559"
Prostate Cancer,2009,NCI,1R01CA140173-01,,Signaling Network Dynamics in Metastatic Prostate Cancer,"LAWRENCE, DAVID",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$405,894"
Prostate Cancer,2009,NCI,5R01CA133891-02,,Energy Balance-Related Hormones & Prostate Cancer Incidence & Progression,"GIOVANNUCCI, EDWARD",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$680,013"
Prostate Cancer,2009,NICHD,5R01HD058614-02,,Regulation of Cellular Zn Redistribution:  A Role of ZnT2,"KELLEHER, SHANNON",PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,PA,"$300,344"
Prostate Cancer,2009,NINR,5R21NR010782-02,,Telephone Counseling to Manage GnRH Agonist Symptom Clusters in Black Men w/ PCa,"BENNETT, ERNEST",MEDICAL COLLEGE OF GEORGIA (MCG),GA,"$183,750"
Prostate Cancer,2009,NINR,5R21NR010772-02,,Mitochondrial Gene Expression Changes Related to a Symptom Cluster in Prostate Ca,"VOSS, JOACHIM",UNIVERSITY OF WASHINGTON,WA,"$233,014"
Prostate Cancer,2009,NINR,5R21NR010383-02,,Prostate Cancer Clinical Decision Making by Diagnosed and High Risk Latino Men,"MALISKI, SALLY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$231,000"
Prostate Cancer,2009,NCI,5R01CA131945-02,,"Metabolic Syndrome, Fatty Acid Synthesis and Prostate Cancer","LODA, MASSIMO",DANA-FARBER CANCER INSTITUTE,MA,"$350,303"
Prostate Cancer,2009,NCI,5F31CA132617-02,,Synthesis and Evaluation of Anti-Tumor Flavanoids,"NIBBS, ANTOINETTE",NORTHWESTERN UNIVERSITY,IL,"$41,176"
Prostate Cancer,2009,NCI,1R01CA140262-01,,"Genetic profiling in PCPT: prostate cancer risk, PSA levels, and chemoprevention","XU, JIANFENG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$641,014"
Prostate Cancer,2009,NCI,5F32CA132332-02,,A Rigid Multivalent Chemical Platform for Targeted Diagnostics and Therapeutics,"NASR, KHALED",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$53,354"
Prostate Cancer,2009,NCI,1R21CA141011-01,,AR Transcriptional Activation Domains in Prostate Cancer Progression,"DEHM, SCOTT",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$166,100"
Prostate Cancer,2009,NCI,1R21CA141036-01,,The Role of Sirt1 in Prostate Cancer Cell Adhesion and Progression,"DAI, YAN",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$214,500"
Prostate Cancer,2009,NCI,1K01CA140711-01,,Inflammatory Mediators of Prostate Cancer Metastasis and Responses to Curcumin,"MARTINEZ-FERRER, MAGALY",VANDERBILT UNIVERSITY,TN,"$91,471"
Prostate Cancer,2009,NCI,2P01CA085859-06A2,5070,"The Detection, Isolation and Characterization of Disseminated Tumor Cells","VESSELLA, ROBERT",UNIVERSITY OF WASHINGTON,WA,"$600,607"
Prostate Cancer,2009,NCI,2P01CA085859-06A2,5073,Transmembrane Proteases and Prostate Carcinogenesis,"VESSELLA, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$597,989"
Prostate Cancer,2009,NCI,2P01CA085859-06A2,5075,Determinants of Response to Type 1 Insulin-Like Growth Factor Inhibition in Prost,"PLYMATE, STEPHEN",UNIVERSITY OF WASHINGTON,WA,"$313,339"
Prostate Cancer,2009,NCI,2P01CA085859-06A2,5077,Biospeciman Core,"VESSELLA, ROBERT",UNIVERSITY OF WASHINGTON,WA,"$555,833"
Prostate Cancer,2009,NCI,2P01CA085859-06A2,5078,Administrative Core,"VESSELLA, ROBERT",UNIVERSITY OF WASHINGTON,WA,"$142,304"
Prostate Cancer,2009,NHGRI,1R01HG005119-01,,Model-Based Methods for Analyzing ChIP Sequencing Data,"QIN, ZHAOHUI",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$295,375"
Prostate Cancer,2009,NCI,1K08CA140946-01,,Understanding the roles of TMPRSS2 and ERG in pathogenesis of prostate cancer.,"CHEN, YU",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$159,149"
Prostate Cancer,2009,NCI,1R15CA141302-01,,Reduced expression of 2 voltage-gated potassium ion-channels in prostate cancer.,"BULLARD-DILLARD, REBECCA",CLAFLIN UNIVERSITY,SC,"$205,331"
Prostate Cancer,2009,NCI,1R01CA134425-01A2,,Prostate-Specific Antigen Practices and Outcomes in the Elderly,"WALTER, LOUISE",NORTHERN CALIFORNIA INSTITUTE RES & EDUC,CA,"$463,572"
Prostate Cancer,2009,NCI,2R01CA058093-16,,Mesenchymal Derived Growth Factors in Prostatic Cancer,"ROWLEY, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$269,842"
Prostate Cancer,2009,NIAID,5F31AI080286-02,,Role of Cytokines in the Persistence of Tolerized T Cells,"OLURINDE, MOBOLAJI",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$46,176"
Prostate Cancer,2009,NCI,1R01CA131123-01A2,,Prevention of prostate cancer growth by a plant alkaloid,"BANERJEE, PARTHA",GEORGETOWN UNIVERSITY,DC,"$318,513"
Prostate Cancer,2009,NCI,2R01CA070196-11A2,,GSTP1 Promoter Hypermethylation in Human Prostate Cancer,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$360,375"
Prostate Cancer,2009,NCMHD,5P20MD001091-05,9003,INFECTIOUS CORE,"LEHKER, MICHAEL",UNIV/TEXAS BROWNSVILLE & SOUTHMOST COLL,TX,"$171,228"
Prostate Cancer,2009,NIEHS,1R21ES017557-01,,Rad9-Based Mouse Model of Prostate Carcinogenesis,"LIEBERMAN, HOWARD",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$240,450"
Prostate Cancer,2009,NCI,1R01CA134463-01A1,,Therapeutics of XIAP Degradation by Zinc Chelators,"KOLENKO, VLADIMIR",FOX CHASE CANCER CENTER,PA,"$325,879"
Prostate Cancer,2009,NCI,1R01CA136621-01A1,,Genome-wide scan for genetic variants associated with early-onset prostate cancer,"COONEY, KATHLEEN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$950,901"
Prostate Cancer,2009,NCI,1R01CA129418-01A2,,"Tak1, a novel prostate cancer tumor suppressor","CRAMER, SCOTT",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$307,100"
Prostate Cancer,2009,NIDDK,2R01DK058242-06A1,,Roles of SRC-3 in Development and Disease,"XU, JIANMING",BAYLOR COLLEGE OF MEDICINE,TX,"$360,375"
Prostate Cancer,2009,NCI,2R01CA106826-05A1,,Developmental Transcription Factors in Prostate Cancer,"MORENO, CARLOS",EMORY UNIVERSITY,GA,"$320,492"
Prostate Cancer,2009,NCI,1R01CA132951-01A2,,Diet change among prostate cancer patients under expectant management,"MARSHALL, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$500,000"
Prostate Cancer,2009,NCI,1R01CA099216-01A2,,Prostate cancer prevention by selenium supplementation,"GOPALAKRISHNA, RAYUDU",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$338,225"
Prostate Cancer,2009,NCI,1R01CA137020-01A1,,Microtubule dependent AR signaling predicts taxane sensitivity,"GIANNAKAKOU, PARASKEVI",WEILL MEDICAL COLLEGE OF CORNELL UNIV,NY,"$350,675"
Prostate Cancer,2009,NCI,1U01CA141535-01,,Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$410,000"
Prostate Cancer,2009,NCI,1U01CA141464-01,,The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can,"THOMAS, GEORGE",UNIVERSITY OF CINCINNATI,OH,"$626,526"
Prostate Cancer,2009,NCI,1R01CA134514-01A2,,FOXO1 Inhibition in Genotoxic Stress Response and Prostate Cancer Survival,"HUANG, HAOJIE",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$313,325"
Prostate Cancer,2009,RMAP,1R21NS066464-01,,Screening for Inhibitors for ERG in Prostate Cancer,"BUSHWELLER, JOHN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$151,500"
Prostate Cancer,2009,NCI,1U01CA141497-01,,Role of FGFR1 signaling in distinct cell lineages in prostate cancer progresssion,"SPENCER, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$750,000"
Prostate Cancer,2009,NCI,1U01CA141502-01,,P3IK Signaling and Biology of Therapeutic Response in Brain and Prostate Tumors,"HOLLAND, ERIC",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$835,000"
Prostate Cancer,2009,NCI,1R01CA132200-01A2,,Vav3 Oncogene Potentiation of Androgen Receptor Signaling in Prostate Cancer.,"BURNSTEIN, KERRY",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$321,530"
Prostate Cancer,2009,RMAP,1R21NS066482-01,,Development of HTS assays for Bcl-2 converters,"SATTERTHWAIT, ARNOLD",BURNHAM INSTITUTE FOR MEDICAL RESEARCH,CA,"$191,000"
Prostate Cancer,2009,NCI,2U01CA084294-11,,Elucidation of cancer pathways and druggable targets using mouse models.,"ABATE-SHEN, CORY",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$835,000"
Prostate Cancer,2009,NCI,1U01CA141508-01,,Uses of GEM models for Translational Cancer Research,"CHIN, LYNDA",DANA-FARBER CANCER INSTITUTE,MA,"$775,000"
Prostate Cancer,2009,NCI,5P30CA022453-28,0006,Proteases Program,"SLOANE, BONNIE",WAYNE STATE UNIVERSITY,MI,"$27,191"
Prostate Cancer,2009,NCI,1P50CA140388-01,8762,GLIPR1-ATM Protein Therapy for Prostate Cancer,"THOMPSON, TIMOTHY",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$254,334"
Prostate Cancer,2009,NCI,1P50CA140388-01,8763,Ligand-Directed Targeting in Prostate Cancer Metastasis,"PASQUALINI, RENATA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$247,305"
Prostate Cancer,2009,NCI,1P50CA140388-01,8764,Scr as a Therapeutic Target in Prostate Cancer Bone Metastases,"GALLICK, GARY",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,131"
Prostate Cancer,2009,NCI,1P50CA140388-01,8765,Targeting FGF Signaling in Prostate Cancer Progression,"NAVONE, NORA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$283,299"
Prostate Cancer,2009,NCI,1P50CA140388-01,8766,Administrative Core,"LOGOTHETIS, CHRISTOPHER",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$254,811"
Prostate Cancer,2009,NCI,1P50CA140388-01,8768,Specimen Core,"TRONCOSO, PATRICIA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$248,234"
Prostate Cancer,2009,NCI,1P50CA140388-01,8769,Developmental Research Program,"THOMPSON, TIMOTHY",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$139,519"
Prostate Cancer,2009,NCI,1P50CA140388-01,8770,Career Development Program,"LIN, SUE-HWA",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$139,519"
Prostate Cancer,2009,NCI,1R41CA135804-01A2,,Novel Inhibitors of Pim Protein Kinases,"KRAFT, ANDREW",VORTEX BIOTECHNOLOGY CORPORATION,SC,"$257,864"
Prostate Cancer,2009,NCI,1R01CA137474-01A1,,ERalpha in prostate homeostasis and cancer,"YEH, SHUYUAN",UNIVERSITY OF ROCHESTER,NY,"$319,550"
Prostate Cancer,2009,NCI,1R43CA142161-01,,Identification of Novel Androgen Receptor Antagonists for the Treatment of Hormon,"NORRIS, JOHN","INTEGRATED ONCOLOGY SOLUTIONS, INC.",NC,"$223,388"
Prostate Cancer,2009,NCI,1R43CA139677-01A1,,Targeted Prodrug Chemotherapy for Prostate Cancer,"WU, JENNY","ACADUCEUS PHARMACEUTICS, INC.",CA,"$159,988"
Prostate Cancer,2009,NCI,1R43CA141870-01,,Application of QDs-based nanotyping technology in the evaluation of chemotherapy,"WANG, Y","OCEAN NANOTECH, LLC",AR,"$198,817"
Prostate Cancer,2009,NCI,1R41CA139785-01A1,,Targeting of Curcumin-genistein nanocomplexes for Treatment of Prostate Cancer,"MOHAPATRA, SUBHRA","TRANSGENEX NANOBIOTECH, INC.",FL,"$158,829"
Prostate Cancer,2009,NCI,1R43CA141923-01,,One Dimensional Hand Held Gamma Ray Scanner,"DAGHIGHIAN, FARHAD","INTRA MEDICAL IMAGING, LLC",CA,"$144,883"
Prostate Cancer,2009,NCI,2R44CA103435-02A1,,Virtual Conversations for Prostate Cancer Decisions,"HARLESS, WILLIAM","INTERACTIVE DRAMA, INC.",MD,"$407,833"
Prostate Cancer,2009,NCI,1R21CA141835-01,,Ultrasound-Guided Navigation in Robot-Assisted Laparoscopic Radical Prostatectomy,"HAN, MISOP",JOHNS HOPKINS UNIVERSITY,MD,"$277,200"
Prostate Cancer,2009,NCI,1F31CA142311-01,,Control of cell growth by mTOR and BMP in prostate cancer,"WAHDAN-ALASWAD, REEMA",CASE WESTERN RESERVE UNIVERSITY,OH,"$41,176"
Prostate Cancer,2009,NCCAM,1F31AT005393-01,,Melatonin as a novel Sirt1 inhibitor for the management of prostate cancer,"HYNES, BRITTNEY",UNIVERSITY OF WISCONSIN MADISON,WI,"$35,776"
Prostate Cancer,2009,NCI,1R03CA142025-01,,Eugenol & 2-methoxyestradiol: combination approach to prostate cancer prevention,"KUMAR, ADDANKI",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$74,208"
Prostate Cancer,2009,NCI,1R03CA138117-01A1,,Chemotherapy and Disability in Older Hormone-Refractory Prostate Cancer Patients,"WELLS, KRISTEN",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$83,500"
Prostate Cancer,2009,NCI,1R03CA139562-01A1,,Identification of Colon Cancer Protein Biomarkers in the Blood,"MOJICA, WILFRIDO",STATE UNIVERSITY OF NEW YORK AT BUFFALO,NY,"$79,250"
Prostate Cancer,2009,NCI,1R03CA136114-01A1,,Assessing Localized Prostate Cancer Post-Treatment Outcomes Among Gay Men,"ALLENSWORTH-DAVIES, DONALD",BOSTON UNIVERSITY MEDICAL CAMPUS,MA,"$81,250"
Prostate Cancer,2009,NCI,1R03CA133935-01A2,,Methylated Galectin-3 DNA as a Marker for Early Diagnosis of Prostate Cancer,"AHMED, HAFIZ",UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE,MD,"$75,000"
Prostate Cancer,2009,NCI,1R01CA134878-01A2,,Control of TGF-Beta/Smad Signaling by mTOR in Prostate Cancer,"DANIELPOUR, DAVID",CASE WESTERN RESERVE UNIVERSITY,OH,"$325,775"
Prostate Cancer,2009,NCI,1P50CA140388-01,5733,"Obesity, Prostate Cancer Progresion and Akt/mTOR Signaling","DIGIOVANNI, JOHN",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$233,615"
Prostate Cancer,2009,NHGRI,3U01HG004726-01S1,,A Multiethnic Genome-Wide Scan of Prostate Cancer,"HAIMAN, CHRISTOPHER",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$408,000"
Prostate Cancer,2009,NCI,5P30CA046934-22,0013,STAFF INVESTIGATORS,"BUNN, PAUL",UNIVERSITY OF COLORADO DENVER,CO,"$62,856"
Prostate Cancer,2009,NCI,4R33CA110092-03,,Improved Spatial Localization for Spectroscopic Imaging,"PANYCH, LAWRENCE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$339,070"
Prostate Cancer,2009,NCI,7R01CA118962-03,,Prevention of Prostate Cancer Progression Using Omega-3 Fatty Acids,"DE GRAFFENRIED, LINDA",UNIVERSITY OF TEXAS AUSTIN,TX,"$284,252"
Prostate Cancer,2009,NCI,5P30CA044579-19,9002,Endocrinology,"SHUPNIK, MARGARET",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$33,910"
Prostate Cancer,2009,NIGMS,5P50GM076547-04,9002,Core--Genomics,"GALITSKI, TIMOTHY",INSTITUTE FOR SYSTEMS BIOLOGY,WA,"$256,886"
Prostate Cancer,2009,NCI,5P30CA014089-34,9001,Molecular and Cell Biology,"LANDOLPH, JOSEPH",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$445,809"
Prostate Cancer,2009,NCI,N02CP45501-16-0-1,,THE AGRICULTURAL HEALTH STUDY - COORDINATING CENTER,"DUNN, MARSHA","WESTAT, INC.",MD,"$148,957"
Prostate Cancer,2009,NIEHS,N02CP45501-16-0-1,,THE AGRICULTURAL HEALTH STUDY - COORDINATING CENTER,"DUNN, MARSHA","WESTAT, INC.",MD,"$400,000"
Prostate Cancer,2009,NCI,261200800001E-12-0-34,,GWAS Studies,"ARTHUR, LARRY",SCIENCE APPLICATIONS INTERNATIONAL CORP,CA,"$3,400,258"
Prostate Cancer,2009,NCI,1R03CA138953-01A1,,Mangostin: A Dietary-Based Xanthone For Prostate Cancer Chemoprevention,"JOHNSON, JEREMY",UNIVERSITY OF WISCONSIN MADISON,WI,"$74,250"
Prostate Cancer,2009,NICHD,5U54HD042454-08,0004,Prostate and Cardiovascular Effects of Male Hormonal Contraceptive Regimens,"BREMNER, WILLIAM",UNIVERSITY OF WASHINGTON,WA,"$65,159"
Prostate Cancer,2009,NCI,1R03CA143962-01,,CBP Bromodomain Antagonists Block Androgen Receptor in Prostate Cancer,"MUJTABA, SYED",MOUNT SINAI SCHOOL OF MEDICINE OF NYU,NY,"$84,750"
Prostate Cancer,2009,NCI,1R01CA140636-01A1,,"Characterizing Mitochondrial DNA Susceptibility to Breast, Colorectal, and Prosta","CHENG, IONA",UNIVERSITY OF HAWAII AT MANOA,HI,"$469,960"
Prostate Cancer,2009,NCI,1R03CA143991-01,,Integrating Quantitative Histological Image and Vascular Density Patterns for Pro,"MADABHUSHI, ANANT",RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK,NJ,"$79,576"
Prostate Cancer,2009,NCI,5P01CA077739-10,0006,Project 1,"MOHLER, JAMES",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$425,457"
Prostate Cancer,2009,NIA,5P01CA077739-10,0006,Project 1,"MOHLER, JAMES",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$24,563"
Prostate Cancer,2009,NCI,5P01CA077739-10,0007,PROJECT 2,"WILSON, ELIZABETH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$308,490"
Prostate Cancer,2009,NIA,5P01CA077739-10,0007,PROJECT 2,"WILSON, ELIZABETH",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$17,810"
Prostate Cancer,2009,NCI,5P01CA077739-10,0008,PROJECT 3,"SMITH, GARY",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$267,608"
Prostate Cancer,2009,NIA,5P01CA077739-10,0008,PROJECT 3,"SMITH, GARY",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$15,450"
Prostate Cancer,2009,NCI,5P01CA077739-10,9002,CORE A,"FRENCH, FRANK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$96,351"
Prostate Cancer,2009,NIA,5P01CA077739-10,9002,CORE A,"FRENCH, FRANK",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$5,563"
Prostate Cancer,2009,NCI,5P01CA077739-10,9003,CORE B,"MOHLER, JAMES",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$165,480"
Prostate Cancer,2009,NIA,5P01CA077739-10,9003,CORE B,"MOHLER, JAMES",UNIVERSITY OF NORTH CAROLINA CHAPEL HILL,NC,"$9,553"
Prostate Cancer,2009,NCI,1R03CA138136-01A1,,Prostate Cancer Education and Screening Pilot Program for African-Americans,"UKOLI, FLORA",MEHARRY MEDICAL COLLEGE,TN,"$76,457"
Prostate Cancer,2009,NCI,1R42CA139822-01A1,,Second Manhood: A Multimedia Intervention for Male Sexual Problems after Cancer,"MARTINETTI, PAUL","DIGITAL SCIENCE TECHNOLOGIES, LLC",PA,"$179,333"
Prostate Cancer,2009,NCI,2R44CA142222-02A1,,Development of a Molecular Targeting Agent for PSMA to Diagnose Metastatic Prosta,"KRONAUGE, JAMES","MOLECULAR INSIGHT PHARMACEUTICALS, INC.",MA,"$488,453"
Prostate Cancer,2009,NCI,5U19CA113317-05,0003,"The Therapeutic Potential, Pharmacology and Toxiciity of Promising Small-Molecule","PIENTA, KENNETH",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$374,197"
Prostate Cancer,2009,NCMHD,1R01MD004038-01,,Pten-loss Dysregulated Pathways in Prostate Cancer,"CHEN, ZHENBANG",MEHARRY MEDICAL COLLEGE,TN,"$366,250"
Prostate Cancer,2009,NCI,3R01CA106504-05S1,,Molecular Mechanisms of Hormone-independence of Prostate Cancer,"QIU, YUN",UNIVERSITY OF MARYLAND BALTIMORE,MD,"$59,064"
Prostate Cancer,2009,NCI,5P30CA014520-36,0002,Program Leaders,"BAILEY, HOWARD",UNIVERSITY OF WISCONSIN MADISON,WI,"$216,581"
Prostate Cancer,2009,NCI,5P01CA108964-05,0001,Androgen Metabolism in the PCPT,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$553,250"
Prostate Cancer,2009,NCI,5P01CA108964-05,0002,Diet and Diet-Related Factors in the PCPT,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$272,125"
Prostate Cancer,2009,NCI,5P01CA108964-05,0003,Insulin-like Growth Factor Axis and Insulin Resistance in PCPT,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$59,092"
Prostate Cancer,2009,NCI,5P01CA108964-05,0004,Genotypic and Phenotypic Studies of Inflammation in PCPT,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$225,668"
Prostate Cancer,2009,NCI,5P01CA108964-05,0005,Oxidative Damage and DNA Repair in the PCPT,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$117,153"
Prostate Cancer,2009,NCI,5P01CA108964-05,9001,Core--Biostatistics/Data Managemente,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$749,550"
Prostate Cancer,2009,NCI,5P01CA108964-05,9002,Core---Pathology/Genotyping,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$251,073"
Prostate Cancer,2009,NCI,4R00CA126160-04,,Genome-Wide Analysis of Transcription Factor Function in Prostate Cancer,"WANG, QIANBEN",OHIO STATE UNIVERSITY,OH,"$247,842"
Prostate Cancer,2009,NCI,3R01CA083940-09S1,,PTH-related peptide and vit D in prostate cancer growth,"FALZON, MIRIAM",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$225,502"
Prostate Cancer,2009,NCI,3U01CA114583-05S1,,CNP for Older Underserved African American Adults,"ALBRECHT, TERRANCE",WAYNE STATE UNIVERSITY,MI,"$83,530"
Prostate Cancer,2009,NCI,5P30CA016087-29,0005,Genitourinary,"FERRARI, ANNA",NEW YORK UNIVERSITY SCHOOL OF MEDICINE,NY,"$25,486"
Prostate Cancer,2009,NCI,N1CN75022A-63-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","FOUAD, MONA",UNIVERSITY OF ALABAMA AT BIRMINGHAM,AL,"$692,835"
Prostate Cancer,2009,NCI,N1CN25524A-78-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","BUYS, SAUNDRA",UNIVERSITY OF UTAH,UT,"$734,554"
Prostate Cancer,2009,NCI,N1CN25518A-92-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","REDING, DOUGLAS",MARSHFIELD CLINIC RESEARCH FOUNDATION,WI,"$767,995"
Prostate Cancer,2009,NCI,N1CN25516A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,WASHINGTON UNIVERSITY,MO,"$611,560"
Prostate Cancer,2009,NCI,N1CN25515A-87-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","YOKOCHI, LANCE",PACIFIC HEALTH RESEARCH INSTITUTE,HI,"$1,078,239"
Prostate Cancer,2009,NCI,N1CN25514A-82-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial",NO PI IDENTIFIED,UNIVERSITY OF COLORADO DENVER,CO,"$1,327,312"
Prostate Cancer,2009,NCI,N1CN25513A-93-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","CHURCH, TIMOTHY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,465,095"
Prostate Cancer,2009,NCI,N1CN25512A-107-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","KVALE, PAUL",HENRY FORD HEALTH SYSTEM,MI,"$1,138,422"
Prostate Cancer,2009,NCI,N1CN25511A-88-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","WEISSFELD, JOEL",,,"$632,887"
Prostate Cancer,2009,NCI,5P01CA067165-11,0002,MR Guided Focused Ultrasound Surgery,"HYNYNEN, KULLERVO",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$231,184"
Prostate Cancer,2009,NCI,5P01CA067165-11,0007,MRI Guided Interventions in the Prostate: Development of an Integrated Image-Base,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$200,987"
Prostate Cancer,2009,NCI,3R01CA114469-05S1,,Mechanisms of Chemoprevention by Resveratrol,"SRIVASTAVA, RAKESH",UNIVERSITY OF TEXAS HLTH CTR AT TYLER,TX,"$19,000"
Prostate Cancer,2009,NIDDK,3R01DK040890-18S1,,Development Estrogenization of the Rat Prostate Gland,"PRINS, GAIL",UNIVERSITY OF ILLINOIS AT CHICAGO,IL,"$16,805"
Prostate Cancer,2009,NCI,7R21CA133632-02,,Biomarker Models of Prostate Cancer Outcome After Radiotherapy,"POLLACK, ALAN",UNIVERSITY OF MIAMI SCHOOL OF MEDICINE,FL,"$178,380"
Prostate Cancer,2009,NCI,5P01CA055075-18,0001,A Prospective Study of Diet and Prostate Cancer,"GIOVANNUCCI, EDWARD",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$516,807"
Prostate Cancer,2009,NCI,5P01CA055075-18,0004,Pooling of Prospective Studies of Diet and Cancer,"SMITH-WARNER, STEPHANIE",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$374,862"
Prostate Cancer,2009,NCI,5P01CA055075-18,9003,Cohort Follow-up and Database Maintenance,"RIMM, ERIC",HARVARD UNIVERSITY (SCH OF PUBLIC HLTH),MA,"$1,193,312"
Prostate Cancer,2009,NCI,7F32CA125955-03,,Deregulated Wnt Signaling in Prostate Cancer,"HOUGHTALING, SCOTT",UNIVERSITY OF NEW MEXICO,NM,"$24,172"
Prostate Cancer,2009,NCMHD,5P20MD002285-03,0001,TGFB SIGNALING IN PROSTATE CANCER CELLS,"KHAN, SHAFIQ AHMED",CLARK ATLANTA UNIVERSITY,GA,"$209,942"
Prostate Cancer,2009,NCMHD,5P20MD002285-03,0002,ALTERED IMMUNE/INFLAMMATORY PATHWAY IN RACIALLY DIVERSE PROSTATE CANCERS,"CHAUDHARY, JAIDEEP",CLARK ATLANTA UNIVERSITY,GA,"$204,882"
Prostate Cancer,2009,NCMHD,5P20MD002285-03,0003,SNAIL-MEDIATED SIGNALING IN PROSTATE CANCER,"ODERO-MARAH, VALERIE",CLARK ATLANTA UNIVERSITY,GA,"$161,357"
Prostate Cancer,2009,NCMHD,5P20MD002285-03,9001,TRAINNING CORE,"CHAUDHARY, JAIDEEP",CLARK ATLANTA UNIVERSITY,GA,"$272,418"
Prostate Cancer,2009,NCMHD,5P20MD002285-03,9002,RESEARCH CORE,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$115,895"
Prostate Cancer,2009,NCMHD,5P20MD002285-03,9003,COMMUNITY OUTREACH CORE,"KHAN, SHAFIQ",CLARK ATLANTA UNIVERSITY,GA,"$156,391"
Prostate Cancer,2009,NCI,5P30CA013696-36,0008,PROSTATE CANCER RESEARCH,"CORDON-CARDO, CARLOS",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$68,511"
Prostate Cancer,2009,NCI,5P01CA048112-17,9003,Core--Biology,"PEZZUTO, JOHN",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$192,475"
Prostate Cancer,2009,NCI,N02CN63300-4-0-1,,Computer Support for Prostate Cancer Screening in the PLCO Cancer Screening Trial,"LAKE, WILLIAM","INFORMATION MANAGEMENT SERVICES, INC.",MD,"$348,161"
Prostate Cancer,2009,OD,2R56CA102537-06,,Role of Cten in Prostate Cancer,"LO, SU HAO",UNIVERSITY OF CALIFORNIA DAVIS,CA,"$239,913"
Prostate Cancer,2009,OD,2R56CA098249-06A1,,Signaling of Integrin Alpha 7,"LUO, JIANHUA",UNIVERSITY OF PITTSBURGH AT PITTSBURGH,PA,"$263,366"
Prostate Cancer,2009,OD,2R56CA080153-10,,Endothelin mechanisms in metastic prostate cancer pain,"STRICHARTZ, GARY",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$377,543"
Prostate Cancer,2009,NIDDK,1P50DK082998-01A1,5842,Intraprostatic Inflammation in the Etiology of Lower Urinary Tract Symptoms.,"PLATZ, ELIZABETH",JOHNS HOPKINS UNIVERSITY,MD,"$215,141"
Prostate Cancer,2009,NCI,5P50CA069568-12,0006,Defining Genetic Risk Factors for Brothers of Men with Prostate Cancer,"COONEY, KATHLEEN",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$267,804"
Prostate Cancer,2009,NCI,5P50CA069568-12,0011,Developmental Research Program,"HUSSAIN, MAHA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$70,400"
Prostate Cancer,2009,NCI,5P50CA069568-12,0019,Carryover from year -09 for Phase II Evaluation of EMD 12194,"PIENTA, KENNETH",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,$1
Prostate Cancer,2009,NCI,5P50CA069568-12,0020,Molecular Sub-Typing of Prostate Cancer Based on Recurrent Gene Fusions,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$282,938"
Prostate Cancer,2009,NCI,5P50CA069568-12,0021,Preclinical Evaluation and Clinical Development of Potent Small-Molecule,"WANG, SHAOMENG",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$279,175"
Prostate Cancer,2009,NCI,5P50CA069568-12,0022,Systemic Inhibition of Monocyte Chemoattractant Protein-1 (MCP-1; CCL2),"LOBERG, ROBERT",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$279,259"
Prostate Cancer,2009,NCI,5P50CA069568-12,0023,Career Development Program,"WOOD, DAVID",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$98,402"
Prostate Cancer,2009,NCI,5P50CA069568-12,9001,Tissue/Informatics Core,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$483,978"
Prostate Cancer,2009,NCI,5P50CA069568-12,9003,Biostatistics Core,"TAYLOR, JEREMY",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$267,652"
Prostate Cancer,2009,NCI,5P50CA069568-12,9005,Administration Core,"PIENTA, KENNETH",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$270,391"
Prostate Cancer,2009,NCI,7R01CA111868-06,,Interactions and Functions of p14ARF in Cancer,"GJERSET, RUTH",TORREY PINES INST FOR MOLECULAR STUDIES,CA,"$271,271"
Prostate Cancer,2009,NCI,5P01CA097132-07,0002,Acid Ceramidase in Prostate Cancer Biology and Therapeutics,"NORRIS, JAMES",MEDICAL UNIVERSITY OF SOUTH CAROLINA,SC,"$222,982"
Prostate Cancer,2009,NCI,5P50CA092131-08,0001,Imaging Prostate Cancer with Engineered PSCA Antibodies,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$425,125"
Prostate Cancer,2009,NCI,5P50CA092131-08,0002,Exploiting PI3K Pathway Inhibitor Therapy in Prostate Cancer,"SAWYER, CHARLES",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$296,266"
Prostate Cancer,2009,NCI,5P50CA092131-08,0003,Lymphagiogenesis and Lymphatic Metastasis in Prostate Cancer,"AGUS, DAVID",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$239,137"
Prostate Cancer,2009,NCI,5P50CA092131-08,0004,Evaluating the Role of IGFBP-3 in Men with Prostate Cancer,"PANTUCK, ALLAN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$206,460"
Prostate Cancer,2009,NCI,5P50CA092131-08,0005,Dietary Fat Modulation and Targeted Therapies for Prostate Cancer Prevention,"ARONSON, WILLIAM",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$206,461"
Prostate Cancer,2009,NCI,5P50CA092131-08,0006,Developmental Research Program,"WITTE, OWEN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$254,539"
Prostate Cancer,2009,NCI,5P50CA092131-08,0007,Career Development Program,"HERSCHMAN, HARVEY",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$190,903"
Prostate Cancer,2009,NCI,5P50CA092131-08,0008,IPBS Supplement,"REITER, ROBERT",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$48,776"
Prostate Cancer,2009,NCI,5P50CA092131-08,9001,Pathology Core,"SAID, JONATHAN",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$141,411"
Prostate Cancer,2009,NCI,5P50CA092131-08,9002,Biostatistics and Informatics Core,"HORVATH, STEVE",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$148,231"
Prostate Cancer,2009,NCI,5P50CA092131-08,9003,Animal Models Core,"WU, HONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$91,919"
Prostate Cancer,2009,NCI,5P50CA092131-08,9004,Imaging Core,"WU, ANNA",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$98,989"
Prostate Cancer,2009,NCI,3R01CA118329-02S1,,Stress-activated signaling in prostate cancer,"KULIK, GEORGE",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$56,236"
Prostate Cancer,2009,NCI,5U54CA116847-05,9004,Career Development and Training Core,"ULRICH, CORNELIA",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$12,174"
Prostate Cancer,2009,NCI,3R01CA122906-03S1,,Dietary histone deactylase inhibitors in prostate cancer prevention,"HO, EMILY",OREGON STATE UNIVERSITY,OR,"$112,315"
Prostate Cancer,2009,NCMHD,5P20MD001632-05,0002,Oxidative stress-induced cellular survival pathways in prostate cancer,"CASIANO, CARLOS",LOMA LINDA UNIVERSITY,CA,"$227,026"
Prostate Cancer,2009,NCMHD,5P20MD001632-05,9002,COMMUNITY CORE,"MONTGOMERY, SUSANNE",LOMA LINDA UNIVERSITY,CA,"$220,831"
Prostate Cancer,2009,NCI,5P30CA069533-13,0002,Solid Tumors,"BEER, TOMASZ",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$52,879"
Prostate Cancer,2009,NCMHD,5P20MD000175-08,0003,ROLES OF INFLAMMATION AND ANDROGEN METABOLISM IN PROSTATE CANCER DISPARITY,"RICHARDSON, RICARDO",NORTH CAROLINA CENTRAL UNIVERSITY,NC,"$97,549"
Prostate Cancer,2009,NCI,5P30CA082103-11,0018,PROSTATE CANCER PROGRAM,"SMALL, ERIC",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,"$71,725"
Prostate Cancer,2009,NCI,3R01CA132803-02S1,,LHRH Agonist Therapy and Cognitive Functioning in Men with Prostate Cancer,"JACOBSEN, PAUL",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$151,803"
Prostate Cancer,2009,NCI,3R01CA122060-03S1,,Phase II Clinical Trial of Polyphenon E in Prostate Cancer,"KUMAR, NAGI",H. LEE MOFFITT CANCER CTR & RES INST,FL,"$147,616"
Prostate Cancer,2009,NCI,5P50CA090381-08,0005,The Androgen Receptor in Hormone Refractory Disease,"BROWN, MYLES",DANA-FARBER CANCER INSTITUTE,MA,"$224,041"
Prostate Cancer,2009,NCI,5P50CA090381-08,0006,Developmental Research Program,"KANTOFF, PHILIP",DANA-FARBER CANCER INSTITUTE,MA,"$143,308"
Prostate Cancer,2009,NCI,5P50CA090381-08,0007,Molecular Signatures of Lethal an Indolent Prostate Cancer,"KANTOFF, PHILIP",DANA-FARBER CANCER INSTITUTE,MA,"$398,681"
Prostate Cancer,2009,NCI,5P50CA090381-08,0008,Genetic and Clinical Characterization of the 8q24 Prostate Cancer Risk Locus,"FREEDMAN, MATTHEW",DANA-FARBER CANCER INSTITUTE,MA,"$216,178"
Prostate Cancer,2009,NCI,5P50CA090381-08,0009,Modulating Transcription Factor Targets Via Chemical Genomics,"OH, WILLIAM",DANA-FARBER CANCER INSTITUTE,MA,"$245,931"
Prostate Cancer,2009,NCI,5P50CA090381-08,0010,Career Development Program,"KANTOFF, PHILIP",DANA-FARBER CANCER INSTITUTE,MA,"$143,309"
Prostate Cancer,2009,NCI,5P50CA090381-08,9002,Core 3,"LODA, MASSIMO",DANA-FARBER CANCER INSTITUTE,MA,"$263,236"
Prostate Cancer,2009,NCI,5P50CA090381-08,9004,"Administration, Evaluation, and Planning Core","KANTOFF, PHILIP",DANA-FARBER CANCER INSTITUTE,MA,"$502,804"
Prostate Cancer,2009,NCI,5P50CA090381-08,9005,Biostatistics and Computational Biology,"REGAN, MEREDITH",DANA-FARBER CANCER INSTITUTE,MA,"$325,512"
Prostate Cancer,2009,NCI,N1CN25476A-81-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Screening Trial","O'BRIEN, BARBARA","WESTAT, INC.",MD,"$2,102,638"
Prostate Cancer,2009,NCI,5U54CA119367-04,0001,Magneto-Nano Protein Chip and Multiplex Sorter for Monitoring Tumor Markers,"WANG, SHAN",STANFORD UNIVERSITY,CA,"$710,978"
Prostate Cancer,2009,NCI,5U54CA119367-04,0004,Proteomic Predictors of Clinical Outcome of Targeted Therapies in Prostate Cancer,"AGUS, DAVID",STANFORD UNIVERSITY,CA,"$1,047,738"
Prostate Cancer,2009,NCI,5U54CA119367-04,0005,Biological Modification of Quantum Dots for in vivo Imaging,"WU, ANNA",STANFORD UNIVERSITY,CA,"$487,188"
Prostate Cancer,2009,NCI,5U54CA126568-04,0001,Evolution of Reactive Stroma in Prostate Cancer Progression,"ROWLEY, DAVID",BAYLOR COLLEGE OF MEDICINE,TX,"$306,475"
Prostate Cancer,2009,NCI,5U54CA126568-04,0002,Neurogenesis in the Prostate Cancer Microenvironment,"AYALA, GUSTAVO",BAYLOR COLLEGE OF MEDICINE,TX,"$275,830"
Prostate Cancer,2009,NCI,5U54CA126568-04,9001,Expression Analysis and Pathology CORE,"ITTMANN, MICHAEL",BAYLOR COLLEGE OF MEDICINE,TX,"$183,887"
Prostate Cancer,2009,NCI,7K99CA129565-02,,The Role of beta-adrenergic Signaling in Prostate Cancer,"YU, JINDAN",NORTHWESTERN UNIVERSITY,IL,"$130,014"
Prostate Cancer,2009,NCI,5S06GM008049-36,0024,Genomic and Functional Analysis of UGT2B17 in Prostate Cells,"GRANT, DELORES",NORTH CAROLINA CENTRAL UNIVERSITY,NC,"$187,755"
Prostate Cancer,2009,NIGMS,5S06GM008049-36,0024,Genomic and Functional Analysis of UGT2B17 in Prostate Cells,"GRANT, DELORES",NORTH CAROLINA CENTRAL UNIVERSITY,NC,$1
Prostate Cancer,2009,NCI,5P01CA106742-04,0001,Phospholipid Signaling in Fish oil-induced Growth Inhibition of Prostate Cancer,"CHEN, YONG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$206,883"
Prostate Cancer,2009,NCI,5P01CA106742-04,0002,Inhibition of Eicosanoids in Prostate Cancer by Fish Oil,"CHEN, YONG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$171,268"
Prostate Cancer,2009,NCI,5P01CA106742-04,0003,Alterations in PAF Synthesis by N-3 Fatty Acids,"CHEN, YONG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$169,775"
Prostate Cancer,2009,NCI,5P01CA106742-04,0004,Anti-cancer mechanisms of n-3 PUFA mediated by syndecan 1,"CHEN, YONG",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$168,844"
Prostate Cancer,2009,NCI,5P50CA086438-09,0006,PET Imaging of Genetically Modified Human T-Cells in Prostate Cancer,"PONOMAREV, VLADIMIR",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$276,091"
Prostate Cancer,2009,NCI,5P50CA086438-09,0007,Non-Invasive Markers of Tumor Response: A Study of Anti-Angiogenic Therapy,"KOUTCHER, JASON",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$227,672"
Prostate Cancer,2009,NCI,5P50CA086438-09,0009,Molecular Imaging of Castrate- Resistance Metastatic Prostate Cancer,"LARSON, STEVEN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$203,991"
Prostate Cancer,2009,NCI,5U54CA126505-04,0002,Paracrine TGF-Beta Signaling in Prostate Cancer Initiation and Progression,"HAYWARD, SIMON",VANDERBILT UNIVERSITY,TN,"$354,576"
Prostate Cancer,2009,NCI,5U54CA126540-04,0001,The Aged Microenvironment as a Contributor to Carcinogenesis,"CAMPISI, JUDITH",UNIVERSITY OF WASHINGTON,WA,"$376,880"
Prostate Cancer,2009,NCI,5U54CA126540-04,0002,Laminin Dysregulation and Prostate Cancer,"PLYMATE, STEPHEN",UNIVERSITY OF WASHINGTON,WA,"$382,198"
Prostate Cancer,2009,NCI,5U54CA126540-04,9001,Tissue and Pathology Core,"VESSELLA, ROBERT",UNIVERSITY OF WASHINGTON,WA,"$154,856"
Prostate Cancer,2009,NCI,5P30CA125123-03,0002,Program Leaders,"DONEHOWER, LARRY",BAYLOR COLLEGE OF MEDICINE,TX,"$150,227"
Prostate Cancer,2009,NCI,5P30CA125123-03,0012,Human Tissue Acquisition & Pathology Resource,"WHEELER, THOMAS",BAYLOR COLLEGE OF MEDICINE,TX,"$131,453"
Prostate Cancer,2009,NCI,2P01CA093900-06A1,6931,Bone Core,"MCCAULEY, LAURIE",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$117,589"
Prostate Cancer,2009,NCI,3U01CA111275-05S1,,Epitomic Biomarkers of Prostate Cancer,"CHINNAIYAN, ARUL",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$449,756"
Prostate Cancer,2009,NCI,4R44CA124032-02,,Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer,"AGUILAR-CORDOVA, ESTUARDO","ADVANTAGENE, INC",MA,"$1,473,388"
Prostate Cancer,2009,NCI,5P50CA097186-08,0001,Genetic Susceptibility to Clinically Aggressive Prostate Cancer,"STANFORD, JANET",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$184,446"
Prostate Cancer,2009,NCI,5P50CA097186-08,0002,The Effect of Radiation on Androgen Receptor Expression and Activity in Prostate,"GARZOTTO, MARK",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$277,144"
Prostate Cancer,2009,NCI,5P50CA097186-08,0003,"Characterization and Targeting of the Cytoprotective Chaperone, HSP27","GLEAVE, MARTIN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$277,503"
Prostate Cancer,2009,NCI,5P50CA097186-08,0004,Mechanisms by Which the Type 1 Insulin-like Growth Factor Inhibition Enhances,"PLYMATE, STEPHEN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$291,197"
Prostate Cancer,2009,NCI,5P50CA097186-08,0005,Maximal Targeted Inhibition of Androgen Signaling for Prostate Cancer Therapy,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$215,039"
Prostate Cancer,2009,NCI,5P50CA097186-08,0006,Developmental Research Program,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$200,436"
Prostate Cancer,2009,NCI,5P50CA097186-08,0007,Career Development Program,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$190,696"
Prostate Cancer,2009,NCI,5P50CA097186-08,0008,IPBS Supplement,"NELSON, PETER",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$67,933"
Prostate Cancer,2009,NCI,5P50CA097186-08,9001,Tissue and Specimen Core,"VESSELLA, ROBERT",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$348,530"
Prostate Cancer,2009,NCI,5P50CA097186-08,9002,Biostatistics,"ETZIONI, RUTH",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$137,435"
Prostate Cancer,2009,NCI,5P50CA097186-08,9003,C-D:  Clinical Core,"YU, EVAN",FRED HUTCHINSON CANCER RESEARCH CENTER,WA,"$169,983"
Prostate Cancer,2009,OD,2R56DK052626-08A2,,NGF Receptor Regulates Prostate Growth,"DJAKIEW, DANIEL",GEORGETOWN UNIVERSITY,DC,"$399,579"
Prostate Cancer,2009,NCMHD,5P20MD000215-08,0001,Development of New therapies for Advanced Prostate Cancer,"JACKSON, KIMBERLY",SPELMAN COLLEGE,GA,"$245,720"
Prostate Cancer,2009,NCMHD,5P20MD000215-08,0002,The Effect of Potential PDK1 Inhibitors on Metastatic Cancers in African American,"WINFIELD, LEYTE",SPELMAN COLLEGE,GA,"$292,843"
Prostate Cancer,2009,OD,2R56CA089720-06,,Integrin Signaling Pathways in Prostate Cancer,"LANGUINO, LUCIA",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$168,602"
Prostate Cancer,2009,NCI,5P50CA086355-10,0005,Molecular Libraries,"WEISSLEDER, RALPH",MASSACHUSETTS GENERAL HOSPITAL,MA,"$253,197"
Prostate Cancer,2009,NCI,5P50CA092629-09,0001,DEVELOPMENT OF MODELS FOR OUTCOME PREDICTION IN EARLY-STAGE PROSTATE CANCER USING,"GERALD, WILLIAM",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$215,739"
Prostate Cancer,2009,NCI,5P50CA092629-09,0002,MOLECULAR CARCINOGENESIS IN THE MOUSE AND HUMAN PROSTATE,"PANDOLFI, PIER PAOLO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$332,386"
Prostate Cancer,2009,NCI,5P50CA092629-09,0003,RATIONAL DESIGN OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN DNA VACCINES,"GREGOR, POLLY",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$257,758"
Prostate Cancer,2009,NCI,5P50CA092629-09,0004,HSP90 AS A TARGET FOR MECHANISM-BASED THERAPY FOR CASTRATION-RESISTANT PROSTATE C,"ROSEN, NEAL",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$362,472"
Prostate Cancer,2009,NCI,5P50CA092629-09,0005,CHECKPOINT BLOCKADE IN IMMUNOTHERAPY OF PROSTATE CANCER,"ALLISON, JAMES",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$216,298"
Prostate Cancer,2009,NCI,5P50CA092629-09,0006,DEVELOPMENTAL RESEARCH PROGRAM,"SCARDINO, PETER",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$89,121"
Prostate Cancer,2009,NCI,5P50CA092629-09,0007,CAREER DEVELOPMENT PROGRAM,"SCARDINO, PETER",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$106,259"
Prostate Cancer,2009,NCI,5P50CA092629-09,9001,BIOSPECIMAN REPOSITORY CORE,"REUTER, VICTOR",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$223,479"
Prostate Cancer,2009,NCI,5P50CA092629-09,9002,BIOSTATISTICS CORE,"HELLER, GLENN",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$133,473"
Prostate Cancer,2009,NCI,5P50CA092629-09,9003,ANIMAL MODELS CORE,"PANDOLFI, PIER PAOLO",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$296,429"
Prostate Cancer,2009,NCI,5P50CA092629-09,9004,ANIMAL IMAGING CORE,"KOUTCHER, JASON",SLOAN-KETTERING INSTITUTE FOR CANCER RES,NY,"$131,594"
Prostate Cancer,2009,NCI,5P50CA093990-08,0009,Developmental Projects,"HUSSAIN, MAHA",UNIVERSITY OF MICHIGAN AT ANN ARBOR,MI,"$104,760"
Prostate Cancer,2009,NCI,3U01CA085067-10S1,,Early Detection of Cancer By Affinity Mass Spectrometry,"SEMMES, OLIVER",EASTERN VIRGINIA MEDICAL SCHOOL,VA,"$409,141"
Prostate Cancer,2009,NCI,5P01CA104177-05,0001,MDA-7/IL-24: Therapy of Prostate Cancer,"FISHER, PAUL",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$490,383"
Prostate Cancer,2009,NCI,5P01CA104177-05,0003,MDA-7/IL-24: Therapy of Ovarian Cancer,"CURIEL, DAVID",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$338,625"
Prostate Cancer,2009,NCI,5P01CA104177-05,9001,Core--Protein Purification,"GUPTA, PANKAJ",COLUMBIA UNIVERSITY HEALTH SCIENCES,NY,"$115,026"
Prostate Cancer,2009,NCI,N1CN25522A-95-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial","ISAACS, CLAUDINE",GEORGETOWN UNIVERSITY,DC,"$649,306"
Prostate Cancer,2009,NCI,3U01CA111244-05S1,,Biomarkers for Prostate and Bladder Cancer,"LIU, ALVIN",UNIVERSITY OF WASHINGTON,WA,"$258,291"
Prostate Cancer,2009,NCI,3R44CA096354-02A2S1,,Zinc-Based Early Detection of Prostate Cancer,"FREDERICKSON, CHRISTOPHER","NEUROBIOTEX, INC.",TX,"$62,500"
Prostate Cancer,2009,NCI,4R00CA125937-03,,Characterization of prostatic stem cells and prostate cancer-initiating cells,"XIN, LI",BAYLOR COLLEGE OF MEDICINE,TX,"$249,000"
Prostate Cancer,2009,NCI,4R00CA129613-03,,Determining the critical in vivo roles of mTOR in cancer,"GUERTIN, DAVID",UNIV OF MASSACHUSETTS MED SCH WORCESTER,MA,"$248,999"
Prostate Cancer,2009,NCI,5P01CA057586-12,0009,PREPARTATORY INTERVENTIONS FOR PROSTATE CANCER PATIENTS,"DIEFENBACH, MICHAEL",UNIVERSITY OF COLORADO DENVER,CO,"$259,522"
Prostate Cancer,2009,NCI,5P20CA132389-03,0001,Planning Stage,"DAVIDSON, ALEC",MOREHOUSE SCHOOL OF MEDICINE,GA,"$72,122"
Prostate Cancer,2009,NCI,5P20CA132389-03,0002,Priority Setting Stage,"DAVIDSON, ALEC",MOREHOUSE SCHOOL OF MEDICINE,GA,"$15,494"
Prostate Cancer,2009,NCI,5P20CA132389-03,0003,Implementation Stage,"DAVIDSON, ALEC",MOREHOUSE SCHOOL OF MEDICINE,GA,"$104,860"
Prostate Cancer,2009,NCI,5U54CA119347-05,0001,AN INFORMATIVE DIAGNOSIS OF A CANCER THROUGH MULTIPARAMETER SERUM ANALYSIS,"HOOD, LEROY",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$510,985"
Prostate Cancer,2009,NCI,5U54CA119347-05,0004,NANOTECHNOLOGIES FOR QUANTITATING PI3-KINASE PATHWAY BIOMARKERS,"SAWYERS, CHARLES",CALIFORNIA INSTITUTE OF TECHNOLOGY,CA,"$541,478"
Prostate Cancer,2009,NCI,5U54CA119349-05,0001,TARGETED POLYMERIC NANOPARTICLES FOR CANCER THERAPY,"LANGER, ROBERT",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$614,343"
Prostate Cancer,2009,NCI,5U54CA119349-05,9005,MOUSE MODEL CORE,"HOUSMAN, DAVID",MASSACHUSETTS INSTITUTE OF TECHNOLOGY,MA,"$196,460"
Prostate Cancer,2009,NCI,5U54CA118638-04,0011,Functional role of Erg in prostate cancer,"OLATINWO, MOSHOOD",MOREHOUSE SCHOOL OF MEDICINE,GA,"$124,336"
Prostate Cancer,2009,NCI,5P50CA058236-15,0021,Tissue Specific Radiation and Chemotherapy Sensitization of Prostate Cancer by,"LUPOLD, SHAWN",JOHNS HOPKINS UNIVERSITY,MD,"$246,328"
Prostate Cancer,2009,NCI,5P50CA058236-15,0022,Evaluation of the Role of PSA Inhibitors in the Prevention and/or Therapy of,"ISAACS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$264,871"
Prostate Cancer,2009,NCI,5P50CA058236-15,0023,Blockade of the Immune Checkpoint Mediated by B7-H1 in Men with Prostate Cancer,"DRAKE, CHARLES",JOHNS HOPKINS UNIVERSITY,MD,"$257,704"
Prostate Cancer,2009,NCI,5P50CA058236-15,0024,Advancing Epidenetic Therapies in Prostate Cancer,"PILI, ROBERTO",JOHNS HOPKINS UNIVERSITY,MD,"$222,984"
Prostate Cancer,2009,NCI,5P50CA058236-15,0025,Identification and Validation of DNA Methylation Biomarkers for High Grade and/or,"YEGNASUBRAMANIAN, SRINIVASAN",JOHNS HOPKINS UNIVERSITY,MD,"$223,655"
Prostate Cancer,2009,NCI,5P50CA058236-15,0026,Analysis of the Serum Marker EPCA-2 in Prostate Cancer,"GETZENBERG, ROBERT",JOHNS HOPKINS UNIVERSITY,MD,"$252,414"
Prostate Cancer,2009,NCI,5P50CA058236-15,9006,Specimen Core,"DE MARZO, ANGELO",JOHNS HOPKINS UNIVERSITY,MD,"$202,250"
Prostate Cancer,2009,NCI,5P50CA058236-15,9007,Administrative Core,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$155,718"
Prostate Cancer,2009,NCI,5P50CA058236-15,9008,Career Development Program,"NELSON, WILLIAM",JOHNS HOPKINS UNIVERSITY,MD,"$150,997"
Prostate Cancer,2009,NCI,5P50CA091956-09,0007,Utility of serum and Tissue Biomarkers for Predicting Response to Androgen Depriv,"KLEE, GEORGE","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$248,344"
Prostate Cancer,2009,NCI,5P50CA091956-09,0008,Prostate Imaging by Vibro-Acoustography,"FATEMI, MOSTAFA","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$217,538"
Prostate Cancer,2009,NCI,5P50CA091956-09,0009,Gene Therapy of Prostate Cancer Using Radioactive Iodine,"MORRIS, JOHN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$246,111"
Prostate Cancer,2009,NCI,5P50CA091956-09,0010,"A Randomized Phase II Clinical trial to Determine the Safety, Tolerability and Ef","VUK-PAVLOVIC, STANIMIR","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$183,870"
Prostate Cancer,2009,NCI,5P50CA091956-09,0011,An Immune Based Therapeutic Approach for Prostate Cancer,"CELIS, ESTEBAN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$352,615"
Prostate Cancer,2009,NCI,5P50CA091956-09,0012,Developemental Research Program,"TINDALL, DONALD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$121,796"
Prostate Cancer,2009,NCI,5P50CA091956-09,0013,Career Development Program,"TINDALL, DONALD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$60,897"
Prostate Cancer,2009,NCI,5P50CA091956-09,9005,Administrative Core,"TINDALL, DONALD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$201,435"
Prostate Cancer,2009,NCI,5P50CA091956-09,9006,Biospecimens Core,"CHEVILLE, JOHN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$217,845"
Prostate Cancer,2009,NCI,5P50CA091956-09,9007,Clinical Core,"DAVIS, BRIAN","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$189,859"
Prostate Cancer,2009,NCI,5P50CA091956-09,9008,Biostatistics Core,"BERGSTRALH, ERIC","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$136,709"
Prostate Cancer,2009,NCI,5P50CA091956-09,9009,Advocate Core,"LAYTON, DONALD","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$2,662"
Prostate Cancer,2009,NCI,5P30CA060553-16,9017,monoclonal antibody,"CHISHOLM, REX",NORTHWESTERN UNIVERSITY,IL,"$111,189"
Prostate Cancer,2009,NCI,5P01CA089021-08,0004,The role of Phosphoinositide 3 Kinase isoforms in Prostate Cancer,"CANTLEY, LEWIS",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$465,637"
Prostate Cancer,2009,NCI,5P01CA089021-08,0005,The Role of AKT in Prostate Cancer,"SELLERS, WILLIAM",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$327,393"
Prostate Cancer,2009,NCI,5P01CA089021-08,0006,AKT-independent Pathways of Phosphoinositide 3-kinase dependent transformation,"SAWYERS, CHARLES",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$428,015"
Prostate Cancer,2009,NCI,5P01CA089021-08,9002,Pathology Core,"LODA, MASSIMO",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$303,930"
Prostate Cancer,2009,NCI,5P01CA089021-08,9004,Transgenic Mouse Core,"DEPINHO, RONALD",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$284,300"
Prostate Cancer,2009,NCI,5P01CA089021-08,9005,Genomics and Bioinformatics,"GOLUB, TODD",BETH ISRAEL DEACONESS MEDICAL CENTER,MA,"$264,977"
Prostate Cancer,2009,NCI,N1CN25404A-41-0-1,,"Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial - Lab",NO PI IDENTIFIED,UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$932,550"
Prostate Cancer,2009,NCI,3R25CA114101-04S2,,Epidemiologic and Basic Science in Cancer Prevention,"MARSHALL, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$114,161"
Prostate Cancer,2009,NCI,5P20CA132388-03,0001,MSM/WCI Partnership To Investigate Mechanisms of Prostate Cancer: Implementation,"HSIEH, CHIA-LING",EMORY UNIVERSITY,GA,"$34,892"
Prostate Cancer,2009,NCI,5P20CA132388-03,0002,MSM/WCI Partnership To Investigate Mechanisms of Prostate Cancer: Planning Stage,"CHUNG, LELAND",EMORY UNIVERSITY,GA,"$103,221"
Prostate Cancer,2009,NCI,5P01CA126804-03,0001,MECHANISM OF SELENIUM POTENTIATION OF FINASTERIDE EFFICACY,"IP, CLEMENT",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$338,718"
Prostate Cancer,2009,NCI,5P01CA126804-03,0002,HYPOXIA AND PRX1 IN FINASTERIDE AND SELENIUM INTERVENTION OF PROSTATE CANCER,"PARK, YOUNG-MEE",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$304,113"
Prostate Cancer,2009,NCI,5P01CA126804-03,0003,A CLINICAL TRIAL WITH FINASTERIDE AND SELENIUM,"MARSHALL, JAMES",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$335,614"
Prostate Cancer,2009,NCI,5P01CA126804-03,9001,BIOSTATISTICS/ADMINISTRATIVE,"IP, CLEMENT",ROSWELL PARK CANCER INSTITUTE CORP,NY,"$91,985"
Prostate Cancer,2009,NCI,3R01CA121110-02S2,,Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma,"WU, HONG",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$37,942"
Prostate Cancer,2009,NCI,5P50CA128301-02,0001,Anti-[18 F] FACBC PET-CT for Characterization of Primary Prostate Carcinoma,"SCHUSTER, DAVID",EMORY UNIVERSITY,GA,"$223,120"
Prostate Cancer,2009,NCI,5P50CA128301-02,0004,Imaging and Targeting Prostate Tumors with a novel near-infrared (NIR).....,"CHUNG, LELAND",EMORY UNIVERSITY,GA,"$199,054"
Prostate Cancer,2009,NCI,3U01CA115996-04S1,,A trial-based MISCAN model for prostate cancer,"DE KONING, HARRY",ERASMUS MEDICAL CENTER,NETH,"$105,209"
Prostate Cancer,2009,NCI,3U10CA095867-08S1,,"Stroger Hospital of Cook County, Department of Surgery,*","LAD, THOMAS",HEKTOEN INSTITUTE FOR MEDICAL RESEARCH,IL,"$100,000"
Prostate Cancer,2009,NCI,5U54CA119341-05,0005,TiO2 nanocomposites for Targeted Treatment and Imaging of Prostate cancer,"WOLOSCHAK, GAYLE",NORTHWESTERN UNIVERSITY,IL,"$485,759"
Prostate Cancer,2009,NCI,3U24CA126480-04S2,,APT: the Analytical Proteomics Team,"REGNIER, FRED",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$41,899"
Prostate Cancer,2009,NCI,3U24CA126480-04S3,,APT: the Analytical Proteomics Team,"REGNIER, FRED",PURDUE UNIVERSITY WEST LAFAYETTE,IN,"$42,515"
Prostate Cancer,2009,NCI,3R01CA059705-17S1,,PATHOGENESIS AND PROGRESSION OF PROSTATE CANCER,"ROY-BURMAN, PRADIP",UNIVERSITY OF SOUTHERN CALIFORNIA,CA,"$59,750"
Prostate Cancer,2009,NCI,7P01CA104898-05,0002,HOMING PEPTIDES FOR THE VASCULATURE IN PROSTATE,"RUOSLAHTI, ERKKI",SIDNEY KIMMEL CANCER CENTER,CA,"$473,208"
Prostate Cancer,2009,NCI,3R01CA118755-02S1,,"Tumor microenvironment, tissue liquidity, and cell interaction in prostate cancer","FOTY, RAMSEY",UNIV OF MED/DENT NJ-R W JOHNSON MED SCH,NJ,"$54,502"
Prostate Cancer,2009,NCI,5U54CA119338-05,0004,Multiplexed Raman Nanotags for Cancer Molecular Profiling,"NATAN, MICHAEL",EMORY UNIVERSITY,GA,"$326,681"
Prostate Cancer,2009,NCI,5U54CA119338-05,0006,Nanoparticle Imaging and Co-Targeting of Cancer and Bone Stroma,"CHUNG, LELAND",EMORY UNIVERSITY,GA,"$296,283"
Prostate Cancer,2009,NCI,5P01CA104106-05,0001,"VEGF, FAK and RAP","PARSONS, J",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$281,714"
Prostate Cancer,2009,NCI,5P01CA104106-05,0002,Neuroendocrine Cells in Prostate Cancer,"PARSONS, SARAH",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$311,012"
Prostate Cancer,2009,NCI,5P01CA104106-05,0003,Integration of Androgen and Growth Factor Signaling in Prostate Cancer,"WEBER, MICHAEL",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$342,516"
Prostate Cancer,2009,NCI,5P01CA104106-05,0004,Nuclear Transport of Androgen Receptor,"PASCHAL, BRYCE",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$280,374"
Prostate Cancer,2009,NCI,5P01CA104106-05,9001,Administrative Core,"THEODORESCU, DAN",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$246,042"
Prostate Cancer,2009,NCI,5P01CA104106-05,9002,"Cell, Animal and Imaging Core","GUISE, THERESA",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$190,379"
Prostate Cancer,2009,NCI,5P01CA104106-05,9003,Tissue Analysis Laboratory,"FRIERSON, HENRY",UNIVERSITY OF VIRGINIA CHARLOTTESVILLE,VA,"$165,421"
Prostate Cancer,2009,NCI,3F31CA130138-01S2,,Identification of small molecule activators of procaspase-7 to caspase-7,"WEST, DIANA",UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN,IL,"$41,176"
Prostate Cancer,2009,NCI,3U01CA116875-05S1,,Chicago Cancer Navigation Project,"ROSEN, STEVEN",NORTHWESTERN UNIVERSITY,IL,"$125,393"
Prostate Cancer,2009,NCI,5U54CA091409-09,0010,Synthesis and MAPK Kinase Inhibitiory Activities in Prostate Tumors,"DENMEADE, SAMUEL",JOHNS HOPKINS UNIVERSITY,MD,"$142,952"
Prostate Cancer,2009,NCI,5U54CA091409-09,0011,Full Project 3: Novel Bifunctional Anti-Andrgoens for Prostate Cancer,"ISAACS, JOHN",JOHNS HOPKINS UNIVERSITY,MD,"$142,951"
Prostate Cancer,2009,NCI,5U54CA091409-09,0012,Resources and Infrastructure: Biostatistics Core,"PIANTADOSI, CLAUDE",JOHNS HOPKINS UNIVERSITY,MD,"$202,352"
Prostate Cancer,2009,NCI,3P50CA105641-05S2,,Determinants of Disparity in Prostate Cancer Outcomes,"REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$623,687"
Prostate Cancer,2009,OD,3P50CA105641-05S2,,Determinants of Disparity in Prostate Cancer Outcomes,"REBBECK, TIMOTHY",UNIVERSITY OF PENNSYLVANIA,PA,"$500,000"
Prostate Cancer,2009,NCI,N01CN35159-8-0-1,,Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents,"LIPPMAN, SCOTT",UNIVERSITY OF TEXAS MD ANDERSON CAN CTR,TX,"$2,136,000"
Prostate Cancer,2009,NCI,2P30CA054174-17,5702,CANCER PREVENTION AND POPULATION SCIENCES,"CURIEL, TYLER",UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT,TX,"$44,382"
Prostate Cancer,2009,NCI,2P30CA077598-11,5749,Tumor Biology & Progression,"MCCARTHY, JAMES",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$26,094"
Prostate Cancer,2009,NCI,2P30CA015083-35,5771,Staff Investigators,"DIASIO, ROBERT","MAYO CLINIC COLL OF MEDICINE, ROCHESTER",MN,"$35,817"
Prostate Cancer,2009,NCI,261200900060C-0-0-1,,SBIR TOPIC 255,"PUSHKO, PETER","MEDIGEN, INC.",MD,"$89,871"
Prostate Cancer,2009,NCRR,5M01RR000188-45,6002,"CLINICAL TRIAL: A PHASE I STUDY OF IN-SITU, NEOADJUVANT, PRE-RADICAL PROSTATECTO","KADMON, DOV",BAYLOR COLLEGE OF MEDICINE,TX,"$9,776"
Prostate Cancer,2009,NCRR,5M01RR010710-12,6089,CLINICAL TRIAL: EARLY CARCINOMA ANTIGENS/ CANCER MARKERS IN ONCOLOGY/ SURFACE PR,"CHEN, WEN",STATE UNIVERSITY NEW YORK STONY BROOK,NY,"$5,479"
Prostate Cancer,2009,NCRR,5M01RR000827-34,6289,"DIET, GENETIC EXPRESSION AND CLINICAL OUTCOMES IN PROSTATE CANCER","SAXE, GORDON",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$20,382"
Prostate Cancer,2009,NCRR,5M01RR000827-34,6337,CLINICAL TRIAL: SWOG S0000:  SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SEL,"SIMONEAU, ANNE",UNIVERSITY OF CALIFORNIA SAN DIEGO,CA,"$21,515"
Prostate Cancer,2009,NCRR,5M01RR007122-18,6678,CLINICAL TRIAL: SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT),"HURD, DAVID",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$10,220"
Prostate Cancer,2009,NCRR,5M01RR007122-18,6697,VITAMIN D & SOY FOR BIOCHEMICALLY RECURRENT PROSTATE CANCER,"FRIED, DANIEL",WAKE FOREST UNIVERSITY HEALTH SCIENCES,NC,"$25,793"
Prostate Cancer,2009,NCRR,5M01RR010284-14,6748,UVD,"KANAAN, YASMINE",HOWARD UNIVERSITY,DC,"$37,700"
Prostate Cancer,2009,NCRR,5M01RR010284-14,6751,EXCERCISE LIPID BW,"TAYLOR, TELETIA",HOWARD UNIVERSITY,DC,"$201,068"
Prostate Cancer,2009,NCRR,5M01RR000865-36,6838,LOW-FAT DIET AND OMEGA-FATTY ACIDS FOR PROSTATE CANCER PREVENTION,"ARONSON, WILLIAM",UNIVERSITY OF CALIFORNIA LOS ANGELES,CA,"$22,844"
Prostate Cancer,2009,NCRR,5M01RR000400-41,7006,SOY ISOFLAVONE DISTRIBUTION IN BIOLOGICAL FLUIDS AS MARKERS OF PROSTATE EXPOSURE,"KURZER, MINDY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$5,854"
Prostate Cancer,2009,NCRR,5M01RR000400-41,7008,DIAGNOSTIC PROSTATE MAGNETIC RESONANCE IMAGING AT 3 TESLA WITH AN ENDORECTAL COI,"METZGER, GREGORY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$1,830"
Prostate Cancer,2009,NCRR,5M01RR000400-41,7067,MAGNETIC RESONANCE IMAGING OF THE PROSTATE AT 7 TESLA,"METZGER, GREGORY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,$732
Prostate Cancer,2009,NCRR,5M01RR018535-07,7257,PROGNOSTIC AND THERAPEUTIC CORRELATION OF CIRCULATING TUMOR CELLS IN CANCER,"VIRA, MANISH",FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH,NY,"$4,190"
Prostate Cancer,2009,NCRR,5M01RR023942-03,7321,HYPOVITAMINOSIS D IN SKIN CANCER PATIENTS,"SKELSEY, MARAL",GEORGETOWN UNIVERSITY,DC,"$51,798"
Prostate Cancer,2009,NCRR,5M01RR000073-46,7441,"S0000, SELENIUM AND VITAMIN E CANCER PREVENTION TRIAL (SELECT)","RAJI, MUKAILA",UNIVERSITY OF TEXAS MEDICAL BR GALVESTON,TX,"$3,208"
Prostate Cancer,2009,NCRR,5M01RR000425-40,7518,CLINICAL TRIAL: THE SELENIUM AND VITAMIN E CHEMOPREVENTION TRIAL (SELECT),"CHLEBOWSKI, ROWAN",LA BIOMED RES INST/ HARBOR UCLA MED CTR,CA,"$485,142"
Prostate Cancer,2009,NCRR,5M01RR000425-40,7524,DIETARY FAT AND INTRAPROSTATIC ANDROGENS: IMPLICATIONS FOR PROSTATE CANCER DE,"WANG, CHRISTINA",LA BIOMED RES INST/ HARBOR UCLA MED CTR,CA,"$30,715"
Prostate Cancer,2009,NCI,N01PC35135-22-0-5,,SEER RRSS #2:  Frequency and Predictors of Missing Data in Site-Specific Variable,"WARD, KEVIN",EMORY UNIVERSITY,GA,"$74,228"
Prostate Cancer,2009,NCRR,5P41RR001395-27,7974,ENVIRONMENTAL EFFECTS ON SIGNAL TRANSDUCTION,"LASKIN, JEFFREY",MARINE BIOLOGICAL LABORATORY,MA,"$22,391"
Prostate Cancer,2009,NCRR,5P41RR000954-32,8006,INCREASING SPECIFICITY IN DETERMINING BIOMARKERS FOR CANCER,"GROSS, MICHAEL",WASHINGTON UNIVERSITY,MO,"$3,495"
Prostate Cancer,2009,NCRR,5P41RR001209-30,8654,MAPPING OF ZINC TO DEFINE THE ROLE OF ZINC IN PROSTATE CANCER,"PALMER, AMY",STANFORD UNIVERSITY,CA,"$1,236"
Prostate Cancer,2009,NCRR,5P41RR008079-17,5226,MULTI-PARAMETRIC MRI DETERMINATION OF PROSTATE CANCER AGGRESSIVENESS AND EXTENT,"METZGER, GREGORY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$25,670"
Prostate Cancer,2009,NCRR,5P41RR008079-17,5227,QUANTITATIVE SPECTROSCOPIC AND ANATOMIC PROSTATE IMAGING AT 7 TESLA,"METZGER, GREGORY",UNIVERSITY OF MINNESOTA TWIN CITIES,MN,"$25,670"
Prostate Cancer,2009,NCRR,5P41RR009784-15,5630,MRI-GUIDED CRYOABLATION: IN VIVO ASSESSMENT OF CANINE PROSTATE,"JOSAN, SONAL",STANFORD UNIVERSITY,CA,"$18,046"
Prostate Cancer,2009,NCRR,5P41RR006009-19,6612,THE CD44:HYALURONAN PROTEIN:CARBOHYDRATE INTERACTION AS A TARGET FOR INVASIVE/M,"GUVENCH, OLGUN",CARNEGIE-MELLON UNIVERSITY,PA,$771
Prostate Cancer,2009,NCRR,5P41RR002584-22,7199,ENZYME - ACTIVATED PROTON MRI CONTRAST AGENTS,"YU, JIAN-XIN",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$8,919"
Prostate Cancer,2009,NCRR,5P41RR002584-22,7203,PROGNOSTIC RADIOLOGY AND THE PATHOPHYSIOLOGY OF TUMORS,"MASON, RALPH",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$8,919"
Prostate Cancer,2009,NCRR,5P41RR002584-22,7238,IMAGING PROSTATE CANCER BY MRI/PET WITH PSMA-TARGETED PROBES,"SUN, XIAOFENG",UNIVERSITY OF TEXAS SW MED CTR/DALLAS,TX,"$8,919"
Prostate Cancer,2009,NCRR,5P41RR018522-07,7257,PILOT STUDY FOR IDENTIFYING URINARY PROSTATE CANCER BIOMARKERS,"LIU, ALVIN",BATTELLE PACIFIC NORTHWEST LABORATORIES,WA,"$65,045"
Prostate Cancer,2009,NCRR,5P41RR001614-27,7622,USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN,"MARKS, JAMES",UNIVERSITY OF CALIFORNIA SAN FRANCISCO,CA,$11
Prostate Cancer,2009,NCRR,2P51RR000163-50,8698,A NOVEL MECHANISM OF ANDROGEN RECEPTOR ACTION,"ROBERTS, CHARLES",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$78,561"
Prostate Cancer,2009,NIA,2P51RR000163-50,8698,A NOVEL MECHANISM OF ANDROGEN RECEPTOR ACTION,"ROBERTS, CHARLES",OREGON HEALTH AND SCIENCE UNIVERSITY,OR,"$1,782"
Prostate Cancer,2009,NCRR,5G12RR003034-24,5389,TRANSCRIPTION FACTORS AND PROSTATE CANCER,"BHAT, GANAPATHY",MOREHOUSE SCHOOL OF MEDICINE,GA,"$87,744"
Prostate Cancer,2009,NIAID,5G12RR003034-24,5389,TRANSCRIPTION FACTORS AND PROSTATE CANCER,"BHAT, GANAPATHY",MOREHOUSE SCHOOL OF MEDICINE,GA,"$6,385"
Prostate Cancer,2009,NCRR,5G12RR003062-23,5402,ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER,"CHAUDHARY, JAIDEEP",CLARK ATLANTA UNIVERSITY,GA,"$250,050"
Prostate Cancer,2009,NCRR,5G12RR003062-23,5403,SNAIL-MEDIATED SIGNALING IN HUMAN PROSTATE CANCER,"ODERO-MARAH, VALERIE",CLARK ATLANTA UNIVERSITY,GA,"$284,813"
Prostate Cancer,2009,NCRR,3G12RR003059-20S2,5504,IDENTIFYING SIGNALING PATHWAYS PROSTATE TUMOR INHIBITION BY LHRH ANALOGS,"TURNER, TIMOTHY",TUSKEGEE UNIVERSITY,AL,"$45,971"
Prostate Cancer,2009,NCRR,5P20RR015563-10,5575,P13K P110BETA IN PROSTATE CANCER PROGRESSION,"LI, BENYI",UNIVERSITY OF KANSAS LAWRENCE,KS,"$40,510"
Prostate Cancer,2009,NCRR,5P20RR016456-08,5634,MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS,"EL SAYED, KHALID",LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,"$55,074"
Prostate Cancer,2009,NCRR,5P20RR016456-08,5635,"REGULATION OF PROSTATE GENE EXPRESSION BY 1,3 BUTADIENE","GRAY, WESLEY",LOUISIANA STATE UNIV A&M COL BATON ROUGE,LA,"$94,188"
Prostate Cancer,2009,NCRR,5P20RR015566-08,5776,COBRE: NDSU: PROJECT 3: MMP-9 IN APOPTOSIS OF PROSTATE CANCER CELLS,"GUO, BIN",NORTH DAKOTA STATE UNIVERSITY,ND,"$137,555"
Prostate Cancer,2009,NCRR,5P20RR016462-08,6072,PROTEOMIC BIOMARKERS IN SERUM OF THE THYROID CANCER PATIENTS,"ZAKRZEWSKA, ELZBIETA",UNIVERSITY OF VERMONT & ST AGRIC COLLEGE,VT,"$3,390"
Prostate Cancer,2009,NCRR,2P20RR016472-09,6347,ROLE OF IGFBP-2 FRAGMENTS IN DEVEL OF ANDROGEN INSENS PROSTATE CANCER,"SIKES, ROBERT",UNIVERSITY OF DELAWARE,DE,"$54,591"
Prostate Cancer,2009,NCRR,2P20RR016480-09,6398,MARKERS OF PROSTATE CANCER PROGRESSION: A TELOMERE-BASED PROTEOMIC APPROACH,"BISOFFI, MARCO",NEW MEXICO STATE UNIVERSITY LAS CRUCES,NM,"$96,544"
Prostate Cancer,2009,NCRR,5P20RR017675-08,6530,REDOX COORDINATED EXTRACELLULAR MATRIX REMODELING IN CANCER,"SIMPSON, MELANIE",UNIVERSITY OF NEBRASKA LINCOLN,NE,"$28,080"
Prostate Cancer,2009,NCRR,2P20RR020152-06,6706,"SOMATIC VARIATIONS OF THE HUMAN DNA POLYMERASE GENES POL?, POL? AND POL? AND PRO","MAKRIDAKIS, NICK",TULANE UNIVERSITY OF LOUISIANA,LA,"$183,993"
Prostate Cancer,2009,NCRR,3P20RR011792-10S2,6904,CLINICAL TRIAL: SELECT,"BEECH, DERRICK",MEHARRY MEDICAL COLLEGE,TN,"$14,440"
Prostate Cancer,2009,NCI,5U41RR019703-05,7000,MR GUIDED THERAPY,"JOLESZ, FERENC",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$23,551"
Prostate Cancer,2009,NCRR,5U41RR019703-05,7000,MR GUIDED THERAPY,"JOLESZ, FERENC",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$22,818"
Prostate Cancer,2009,NIBIB,5U41RR019703-05,7000,MR GUIDED THERAPY,"JOLESZ, FERENC",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$8,424"
Prostate Cancer,2009,NCI,5U41RR019703-05,7001,TARGETED PROSTATE BIOPSY USING MATHEMATICAL OPTIMIZATION,"DAVATZIKOS, CHRISTOS",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$23,551"
Prostate Cancer,2009,NCRR,5U41RR019703-05,7001,TARGETED PROSTATE BIOPSY USING MATHEMATICAL OPTIMIZATION,"DAVATZIKOS, CHRISTOS",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$22,818"
Prostate Cancer,2009,NIBIB,5U41RR019703-05,7001,TARGETED PROSTATE BIOPSY USING MATHEMATICAL OPTIMIZATION,"DAVATZIKOS, CHRISTOS",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$8,424"
Prostate Cancer,2009,NCI,5U41RR019703-05,7004,IMPROVED SPACIAL LOCALIZATION FOR SPECTROSCOPIC IMAGING,"PANYCH, LAWRENCE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$23,551"
Prostate Cancer,2009,NCRR,5U41RR019703-05,7004,IMPROVED SPACIAL LOCALIZATION FOR SPECTROSCOPIC IMAGING,"PANYCH, LAWRENCE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$22,818"
Prostate Cancer,2009,NIBIB,5U41RR019703-05,7004,IMPROVED SPACIAL LOCALIZATION FOR SPECTROSCOPIC IMAGING,"PANYCH, LAWRENCE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$8,424"
Prostate Cancer,2009,NCI,5U41RR019703-05,7005,MR GUIDED FOCUSED ULTRASOUND SURGERY FOR PROSTATE CANCER,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$23,551"
Prostate Cancer,2009,NCRR,5U41RR019703-05,7005,MR GUIDED FOCUSED ULTRASOUND SURGERY FOR PROSTATE CANCER,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$22,818"
Prostate Cancer,2009,NIBIB,5U41RR019703-05,7005,MR GUIDED FOCUSED ULTRASOUND SURGERY FOR PROSTATE CANCER,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$8,424"
Prostate Cancer,2009,NCI,5U41RR019703-05,7008,ENABLING TECHNOLOGIES FOR MRI-GUIDED PROSTATE INTERVENTIONS,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$47,102"
Prostate Cancer,2009,NCRR,5U41RR019703-05,7008,ENABLING TECHNOLOGIES FOR MRI-GUIDED PROSTATE INTERVENTIONS,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$45,635"
Prostate Cancer,2009,NIBIB,5U41RR019703-05,7008,ENABLING TECHNOLOGIES FOR MRI-GUIDED PROSTATE INTERVENTIONS,"TEMPANY, CLARE",BRIGHAM AND WOMEN'S HOSPITAL,MA,"$16,848"
Prostate Cancer,2009,NCI,261200900051C-0-0-1,,BIOMEDICAL (BASIC),"HO, DAVID","IMAGINAB, INC.",CA,"$199,363"
Prostate Cancer,2009,NCI,261200900055C-0-0-1,,SBIR TOPIC 259: QUANTITATIVE TISSUE IMAGING FOR CLINICAL DIAGNOSIS AND PROGNOSIS,"LERNHARDT, WALDEMAR","PROVERI, INC.",CA,"$139,270"
Prostate Cancer,2009,NCI,Y1CN4003-7-0-1,,Bioactive Nutrient Effects of Prostate & Mammary CA,NO PI IDENTIFIED,,,"$13,000"
Prostate Cancer,2009,NIA,1ZIAAG000633-20,,Health And Disease Status In The Blsa--the Prostate Gland,"METTER, EARL",NIH,,"$70,479"
Prostate Cancer,2009,NIA,1ZIAAG000973-01,,Effects of androgen deprivation therapy on metabolism in men with prostate CA,"CHIA, CHEE",NIH,,"$211,436"
Prostate Cancer,2009,NCCAM,1ZIAAT000006-08,,The Effects Of CAM Biological Agents In Human Prostate Cells In Vitro,"ARNOLD, JULIA",NIH,,"$1,578,000"
Prostate Cancer,2009,NCI,1ZIABC005177-29,,Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA,"POIRIER, MIRIAM",NIH,,"$663,266"
Prostate Cancer,2009,NCI,1ZIABC005652-20,,Cancer and Inflammation - Genetics and Function,"DEAN, MICHAEL",NIH,,"$701,821"
Prostate Cancer,2009,NCI,1ZIABC005740-17,,Transgenic Models for Prostate and Breast Cancer,"GREEN, JEFFREY",NIH,,"$1,214,015"
Prostate Cancer,2009,NCI,1ZIABC010253-14,,Molecular Mechanisms of Growth Factor Modulated Proliferation,"FARRAR, WILLIAM",NIH,,"$247,942"
Prostate Cancer,2009,NCI,1ZIABC010413-08,,Study of hereditary prostate cancer and human artificial chromosomes,"LARIONOV, VLADIMIR",NIH,,"$1,499,749"
Prostate Cancer,2009,NCI,1ZIABC010425-10,,Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials,"SCHLOM, JEFFREY",NIH,,"$538,509"
Prostate Cancer,2009,NCI,1ZIABC010453-07,,Identify SNPs and Polymorphisms Involved in the Development of Prostate Cancer,"FIGG, WILLIAM",NIH,,"$594,718"
Prostate Cancer,2009,NCI,1ZIABC010499-07,,Maryland Prostate Cancer Case-Control Study,"AMBS, STEFAN",NIH,,"$770,424"
Prostate Cancer,2009,NCI,1ZIABC010547-07,,Development of Drugs That Target Prostate Cancer,"FIGG, WILLIAM",NIH,,"$297,359"
Prostate Cancer,2009,NCI,1ZIABC010607-06,,Ras-mediated signals in human epithelial cell transformation and metastasis,"KELLY, KATHLEEN",NIH,,"$297,751"
Prostate Cancer,2009,NCI,1ZIABC010624-06,,The Molecular Profile of Prostate Tumors in African-American Men,"AMBS, STEFAN",NIH,,"$481,515"
Prostate Cancer,2009,NCI,1ZIABC010655-05,,Prostate Cancer Imaging,"CHOYKE, PETER",NIH,,"$1,968,645"
Prostate Cancer,2009,NCI,1ZIABC010660-05,,The Molecular Profile of Prostate Tumors in Smokers,"AMBS, STEFAN",NIH,,"$192,606"
Prostate Cancer,2009,NCI,1ZIABC010666-05,,Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines,"GULLEY, JAMES",NIH,,"$863,733"
Prostate Cancer,2009,NCI,1ZIABC010695-05,,Prostate stem cells and cancer stem cells,"VOGEL, JONATHAN",NIH,,"$289,855"
Prostate Cancer,2009,NCI,1ZIABC010731-04,,In Vivo MRI imaging of single metastatic cells,"KELLY, KATHLEEN",NIH,,"$148,875"
Prostate Cancer,2009,NCI,1ZIABC010761-04,,Studies of Proteins with Important Roles in Immunology andor Cancer Biology,"LUBKOWSKI, JACEK",NIH,,"$661,102"
Prostate Cancer,2009,NCI,1ZIABC010802-03,,Tumor stem cells and metastatic outcomes in mouse models of prostate cancer,"KELLY, KATHLEEN",NIH,,"$744,376"
Prostate Cancer,2009,NCI,1ZIABC010834-03,,"Identifying Diagnostic Markers for Cervical Cancer, Breast Cancer, and Prostate","RIED, THOMAS",NIH,,"$454,947"
Prostate Cancer,2009,NCI,1ZIABC010880-02,,Mechanisms of Prostate Tumorigenesis Using Genetically Engineered Mouse Models,"TESSAROLLO, LINO",NIH,,"$644,453"
Prostate Cancer,2009,NCI,1ZIABC010886-02,,Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer,"AMBS, STEFAN",NIH,,"$288,909"
Prostate Cancer,2009,NCI,1ZIABC010908-02,,Role of MxA in Human Prostate Cancer,"MUSHINSKI, J.",NIH,,"$22,288"
Prostate Cancer,2009,NCI,1ZIABC010942-02,,Diacylglycerol Lactones as C1 Ligands for Protein Kinase C and Related Proteins,"MARQUEZ, VICTOR",NIH,,"$257,012"
Prostate Cancer,2009,NCI,1ZIABC010945-02,,Clinical trials employing cancer vaccine combination therapies,"GULLEY, JAMES",NIH,,"$863,733"
Prostate Cancer,2009,NCI,1ZIABC010954-02,,Tumor Growth and Microenvironment Influence T Cell Tolerance to Tumor Antigens,"HURWITZ, ARTHUR",NIH,,"$498,243"
Prostate Cancer,2009,NCI,1ZIABC010972-02,,Identification of human tumor-associated antigens,"TSANG, KWONG YOK",NIH,,"$896,832"
Prostate Cancer,2009,NCI,1ZIABC010973-02,,Analyses of human T regulatory cells,"TSANG, KWONG YOK",NIH,,"$384,357"
Prostate Cancer,2009,NCI,1ZIABC010975-02,,Vaccine and radiation for the therapy of human cancers,"HODGE, JAMES",NIH,,"$384,564"
Prostate Cancer,2009,NCI,1ZIABC011053-02,,TMPRSS2-ERG chromosomal translocations and prostate cancer,"KELLY, KATHLEEN",NIH,,"$148,875"
Prostate Cancer,2009,NCI,1ZIABC011081-02,,Prostate Section,"PINTO, PETER",NIH,,"$148,388"
Prostate Cancer,2009,NCI,1ZIABC011123-02,,Development of Grb2 SH2 Domain Antagonists as Anti-Cancer Therapeutics,"BOTTARO, DONALD",NIH,,"$119,334"
Prostate Cancer,2009,NCI,1ZIABC011169-01,,Inflammation and Prostate Carcinogenesis,"HURWITZ, ARTHUR",NIH,,"$249,121"
Prostate Cancer,2009,NCI,1ZIACO020003-01,,Office of Cancer Genomics,"NIEDERHUBER, JOHN",NIH,,"$2,197,998"
Prostate Cancer,2009,NCI,1ZIACP005804-15,,Pharmacogenetic Studies,"CAPORASO, NEIL",NIH,,"$627,804"
Prostate Cancer,2009,NCI,1ZIACP010119-14,,Studies of Occupational Cancer (Pesticides),"ALAVANJA, MICHAEL",NIH,,"$975,974"
Prostate Cancer,2009,NCI,1ZIACP010136-14,,Cancer Risk in Human Populations,"SILVERMAN, DEBRA",NIH,,"$1,123,133"
Prostate Cancer,2009,NCI,1ZIACP010169-08,,"Nutrition, Metabolism, and Cancer","ZIEGLER, REGINA",NIH,,"$366,544"
Prostate Cancer,2009,NCI,1ZIACP010180-08,,Prostate Cancer Studies,"HSING, ANN",NIH,,"$1,881,540"
Prostate Cancer,2009,NCI,1ZIACP010187-05,,Cancer Genetic Markers of Susceptibility,"HOOVER, ROBERT",NIH,,"$398,548"
Prostate Cancer,2009,NCI,1ZIACP010195-03,,"Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study","ALBANES, DEMETRIUS",NIH,,"$1,155,055"
Prostate Cancer,2009,NIDCR,1ZIADE000074-37,,Bone And Tooth Matrix Biochemistry And Metabolism,"FISHER, LARRY",NIH,,"$748,923"
Prostate Cancer,2009,NIEHS,1ZIAES050144-15,,"Role Of Lipids In Colon, Breast, And Other Cancers","ELING, THOMAS",NIH,,"$467,820"
Prostate Cancer,2009,NIEHS,1ZIAES050167-12,,Quantitative Mass Spectrometry,"TOMER, KENNETH",NIH,,"$342,783"
Prostate Cancer,2009,NICHD,1ZIAHD000193-24,,Angiotensin II Receptors And Signaling Mechanisms,"CATT, KEVIN",NIH,,"$663,660"
Prostate Cancer,2009,NHGRI,1ZIAHG200325-05,,Finding Genes for Cancer Susceptibility and Growth Regulation,"OSTRANDER, ELAINE",NIH,,"$2,221,247"
Prostate Cancer,2009,NHGRI,1ZIAHG200331-05,,Genetic Epidemiology of Cancer,"BAILEY-WILSON, JOAN",NIH,,"$776,735"
Prostate Cancer,2009,NIDDK,1ZIAHL006004-02,,Novel Full-length Cdnas Differentially Expressed During Hematopoietic Commitment,"RODGERS, GRIFFIN",NIH,,"$342,927"
Prostate Cancer,2009,NCI,1ZIASC004020-32,,"Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS","BERZOFSKY, JAY",NIH,,"$2,741,261"
Prostate Cancer,2009,NCI,1ZIASC006538-16,,Development of Angiogenesis Inhibitors,"FIGG, WILLIAM",NIH,,"$297,359"
Prostate Cancer,2009,NCI,1ZIASC010098-09,,The Evaluation of Novel Therapeutics for Genitourinary Malignancies,"DAHUT, WILLIAM",NIH,,"$695,031"
Prostate Cancer,2009,NCI,1ZIASC010437-09,,Molecular Pathology of Cancer,"EMMERT-BUCK, MICHAEL",NIH,,"$610,480"
Prostate Cancer,2009,NCI,1ZICBC010947-02,,Cell and Cancer Biology Branch Confocal Microscopy Core,"WARD, YVONA",NIH,,"$457,582"
Prostate Cancer,2009,NCI,1ZICBC011044-02,,Clinical Tissue Procurement and Sequencing Core,"VOCKE, CATHY",NIH,,"$353,655"
Prostate Cancer,2009,NCI,1ZIDBC011089-02,,Clinical Nursing and Data Management Core,"LINEHAN, WILLIAM",NIH,,"$1,394,300"
Prostate Cancer,2009,NCI,1ZIGBC010856-03,,Basic and Preclinical Animal Models in support of Cancer and HIVAIDS Research,"CUSTER, MARY",NIH,,"$16,074,264"
